메뉴 건너뛰기




Volumn 76, Issue SUPPL. 113, 2009, Pages

Foreword

(177)  Eckardt, Kai Uwe a   Kasiske, Bertram L a   Abboud, Omar a   Abu Alfa, Ali a   Abutaleb, Nasrulla a   Acharya, Vidya a   Adler, Sharon a   Adragao, Teresa a   Agarwal, Anil a   Akizawa, Tadao a   Akl, Ahmed a   Al Rukhaimi, Mona a   Andress, Dennis a   Arici, Mustafa a   Tomas Arriola, Mariano a   Ashurst, Ione a   Badr, Kamal a   Bakr, Ashraf a   Balogun, Rasheed A a   Becker, Bryan a   more..

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HUMAN; MEDICAL CARE; MEDICAL LITERATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW;

EID: 68249137037     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.188     Document Type: Editorial
Times cited : (242)

References (477)
  • 1
    • 4644333725 scopus 로고    scopus 로고
    • The burden of kidney disease: Improving global outcomes
    • Eknoyan G, Lameire N, Barsoum R et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66: 1310-1314.
    • (2004) Kidney Int , vol.66 , pp. 1310-1314
    • Eknoyan, G.1    Lameire, N.2    Barsoum, R.3
  • 2
    • 33645757920 scopus 로고    scopus 로고
    • Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    • Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953.
    • (2006) Kidney Int , vol.69 , pp. 1945-1953
    • Moe, S.1    Drueke, T.2    Cunningham, J.3
  • 3
    • 0033603794 scopus 로고    scopus 로고
    • Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group
    • Bucher HC, Guyatt GH, Cook DJ et al. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA 1999; 282: 771-778.
    • (1999) JAMA , vol.282 , pp. 771-778
    • Bucher, H.C.1    Guyatt, G.H.2    Cook, D.J.3
  • 4
    • 0030854892 scopus 로고    scopus 로고
    • Formulating questions and locating primary studies for inclusion in systematic reviews
    • Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med 1997; 127: 380-387.
    • (1997) Ann Intern Med , vol.127 , pp. 380-387
    • Counsell, C.1
  • 5
    • 83055172414 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-201.
    • (2003) Am J Kidney Dis , vol.42
  • 6
    • 25844525840 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005; 46: S1-121.
    • (2005) Am J Kidney Dis , vol.46
  • 7
    • 16244381117 scopus 로고    scopus 로고
    • Interventions for preventing bone disease in kidney transplant recipients: A systematic review of randomized controlled trials
    • Palmer SC, Strippoli GF, McGregor DO. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis 2005; 45: 638-649.
    • (2005) Am J Kidney Dis , vol.45 , pp. 638-649
    • Palmer, S.C.1    Strippoli, G.F.2    McGregor, D.O.3
  • 8
    • 38449117963 scopus 로고    scopus 로고
    • Meta-analysis: Vitamin D compounds in chronic kidney disease
    • Palmer SC, McGregor DO, Macaskill P et al. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007; 147: 840-853.
    • (2007) Ann Intern Med , vol.147 , pp. 840-853
    • Palmer, S.C.1    McGregor, D.O.2    Macaskill, P.3
  • 9
    • 33748075128 scopus 로고    scopus 로고
    • Effects of bisphosphonates on bone loss in the first year after renal transplantation - a meta-analysis of randomized controlled trials
    • Mitterbauer C, Schwarz C, Haas M et al. Effects of bisphosphonates on bone loss in the first year after renal transplantation - a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2006; 21: 2275-2281.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 2275-2281
    • Mitterbauer, C.1    Schwarz, C.2    Haas, M.3
  • 10
    • 33646493386 scopus 로고    scopus 로고
    • Meta-analysis of biochemical and patient-level effects of calcimimetic therapy
    • Strippoli GF, Palmer S, Tong A et al. Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. Am J Kidney Dis 2006; 47: 715-726.
    • (2006) Am J Kidney Dis , vol.47 , pp. 715-726
    • Strippoli, G.F.1    Palmer, S.2    Tong, A.3
  • 11
    • 0041365764 scopus 로고    scopus 로고
    • Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients
    • Burke SK, Dillon MA, Hemken DE et al. Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients. Adv Ren Replace Ther 2003; 10: 133-145.
    • (2003) Adv Ren Replace Ther , vol.10 , pp. 133-145
    • Burke, S.K.1    Dillon, M.A.2    Hemken, D.E.3
  • 12
    • 0038187803 scopus 로고    scopus 로고
    • A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients
    • D'Haese PC, Spasovski GB, Sikole A et al. A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int 2003; 63 (Suppl 85): S73-78.
    • (2003) Kidney Int , vol.63 , Issue.SUPPL. 85
    • D'Haese, P.C.1    Spasovski, G.B.2    Sikole, A.3
  • 13
    • 29244481652 scopus 로고    scopus 로고
    • The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease
    • Freemont AJ, Hoyland JA, Denton J. The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease. Clin Nephrol 2005; 64: 428-437.
    • (2005) Clin Nephrol , vol.64 , pp. 428-437
    • Freemont, A.J.1    Hoyland, J.A.2    Denton, J.3
  • 14
    • 84974793861 scopus 로고    scopus 로고
    • Grading quality of evidence and strength of recommendations
    • Atkins D, Best D, Briss PA et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490.
    • (2004) BMJ , vol.328 , pp. 1490
    • Atkins, D.1    Best, D.2    Briss, P.A.3
  • 15
    • 34447281257 scopus 로고    scopus 로고
    • Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism
    • Sterrett JR, Strom J, Stummvoll HK et al. Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol 2007; 68: 10-17.
    • (2007) Clin Nephrol , vol.68 , pp. 10-17
    • Sterrett, J.R.1    Strom, J.2    Stummvoll, H.K.3
  • 16
    • 34447575821 scopus 로고    scopus 로고
    • Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD)
    • Fujii N, Hamano T, Mikami S et al. Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD). Nephrol Dial Transplant 2007; 22: 1601-1607.
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 1601-1607
    • Fujii, N.1    Hamano, T.2    Mikami, S.3
  • 17
    • 25844515848 scopus 로고    scopus 로고
    • Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols
    • Salusky IB, Goodman WG, Sahney S et al. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol 2005; 16: 2501-2508.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2501-2508
    • Salusky, I.B.1    Goodman, W.G.2    Sahney, S.3
  • 18
    • 0031684403 scopus 로고    scopus 로고
    • Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration
    • Salusky IB, Kuizon BD, Belin TR et al. Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 1998; 54: 907-914.
    • (1998) Kidney Int , vol.54 , pp. 907-914
    • Salusky, I.B.1    Kuizon, B.D.2    Belin, T.R.3
  • 20
    • 0037962048 scopus 로고    scopus 로고
    • Renal bone disease: A new conceptual framework for the interpretation of bone histomorphometry
    • Parfitt AM. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 2003; 12: 387-403.
    • (2003) Curr Opin Nephrol Hypertens , vol.12 , pp. 387-403
    • Parfitt, A.M.1
  • 21
    • 14544289564 scopus 로고    scopus 로고
    • Utilization of bone histomorphometry in renal osteodystrophy: Demonstration of a new approach using data from a prospective study of lanthanum carbonate
    • Freemont T, Malluche HH. Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate. Clin Nephrol 2005; 63: 138-145.
    • (2005) Clin Nephrol , vol.63 , pp. 138-145
    • Freemont, T.1    Malluche, H.H.2
  • 22
    • 33845343267 scopus 로고    scopus 로고
    • Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    • Uhlig K, Macleod A, Craig J et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 70: 2058-2065.
    • (2006) Kidney Int , vol.70 , pp. 2058-2065
    • Uhlig, K.1    Macleod, A.2    Craig, J.3
  • 23
    • 43749120754 scopus 로고    scopus 로고
    • Going from evidence to recommendations
    • Guyatt GH, Oxman AD, Kunz R et al. Going from evidence to recommendations. BMJ 2008; 336: 1049-1051.
    • (2008) BMJ , vol.336 , pp. 1049-1051
    • Guyatt, G.H.1    Oxman, A.D.2    Kunz, R.3
  • 24
    • 43249093669 scopus 로고    scopus 로고
    • What is 'quality of evidence' and why is it important to clinicians?
    • Guyatt GH, Oxman AD, Kunz R et al. What is 'quality of evidence' and why is it important to clinicians? BMJ 2008; 336: 995-998.
    • (2008) BMJ , vol.336 , pp. 995-998
    • Guyatt, G.H.1    Oxman, A.D.2    Kunz, R.3
  • 25
    • 0037323867 scopus 로고    scopus 로고
    • Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project
    • AGREE Collaboration
    • AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003; 12: 18-23.
    • (2003) Qual Saf Health Care , vol.12 , pp. 18-23
  • 26
    • 0141685684 scopus 로고    scopus 로고
    • Standardized reporting of clinical practice guidelines: A proposal from the Conference on Guideline Standardization
    • Shiffman RN, Shekelle P, Overhage JM et al. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139: 493-498.
    • (2003) Ann Intern Med , vol.139 , pp. 493-498
    • Shiffman, R.N.1    Shekelle, P.2    Overhage, J.M.3
  • 27
    • 19444362507 scopus 로고    scopus 로고
    • Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system
    • Atkins D, Briss PA, Eccles M et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res 2005; 5: 25.
    • (2005) BMC Health Serv Res , vol.5 , pp. 25
    • Atkins, D.1    Briss, P.A.2    Eccles, M.3
  • 28
    • 33845700085 scopus 로고    scopus 로고
    • Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
    • Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38.
    • (2007) Kidney Int , vol.71 , pp. 31-38
    • Levin, A.1    Bakris, G.L.2    Molitch, M.3
  • 29
    • 41249099161 scopus 로고    scopus 로고
    • Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004
    • Vassalotti JA, Uribarri J, Chen SC et al. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008; 51: S56-68.
    • (2008) Am J Kidney Dis , vol.51
    • Vassalotti, J.A.1    Uribarri, J.2    Chen, S.C.3
  • 30
    • 44449176014 scopus 로고    scopus 로고
    • Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: The CHOICE study
    • Melamed ML, Eustace JA, Plantinga LC et al. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study. Nephrol Dial Transplant 2008; 23: 1650-1658.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 1650-1658
    • Melamed, M.L.1    Eustace, J.A.2    Plantinga, L.C.3
  • 31
    • 55749092278 scopus 로고    scopus 로고
    • Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients
    • Regidor DL, Kovesdy CP, Mehrotra R et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 2008; 19: 2193-2203.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 2193-2203
    • Regidor, D.L.1    Kovesdy, C.P.2    Mehrotra, R.3
  • 32
    • 49749139700 scopus 로고    scopus 로고
    • High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death
    • Blayney MJ, Pisoni RL, Bragg-Gresham JL et al. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int 2008; 74: 655-63.
    • (2008) Kidney Int , vol.74 , pp. 655-663
    • Blayney, M.J.1    Pisoni, R.L.2    Bragg-Gresham, J.L.3
  • 33
    • 49749113618 scopus 로고    scopus 로고
    • Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
    • Tentori F, Blayney MJ, Albert JM et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008; 52: 519-530.
    • (2008) Am J Kidney Dis , vol.52 , pp. 519-530
    • Tentori, F.1    Blayney, M.J.2    Albert, J.M.3
  • 34
    • 0018888025 scopus 로고
    • Early diagnosis of juvenile renal osteodystrophy
    • Norman ME, Mazur AT, Borden St et al. Early diagnosis of juvenile renal osteodystrophy. J Pediatr 1980; 97: 226-232.
    • (1980) J Pediatr , vol.97 , pp. 226-232
    • Norman, M.E.1    Mazur, A.T.2    Borden, S.3
  • 35
    • 33846660116 scopus 로고    scopus 로고
    • Reduced systolic myocardial function in children with chronic renal insufficiency
    • Chinali M, de Simone G, Matteucci MC et al. Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol 2007; 18: 593-598.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 593-598
    • Chinali, M.1    de Simone, G.2    Matteucci, M.C.3
  • 36
    • 13244264697 scopus 로고    scopus 로고
    • Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D
    • Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317-322.
    • (2005) J Nutr , vol.135 , pp. 317-322
    • Hollis, B.W.1
  • 37
    • 56749133159 scopus 로고    scopus 로고
    • Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D
    • Hollis BW. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes 2008; 15: 489-494.
    • (2008) Curr Opin Endocrinol Diabetes Obes , vol.15 , pp. 489-494
    • Hollis, B.W.1
  • 38
    • 67650391473 scopus 로고    scopus 로고
    • Optimal vitamin D status
    • Heaney RP. Optimal vitamin D status. J Bone Miner Res 2009; 24: 755.
    • (2009) J Bone Miner Res , vol.24 , pp. 755
    • Heaney, R.P.1
  • 39
    • 27744533661 scopus 로고    scopus 로고
    • Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake
    • Steingrimsdottir L, Gunnarsson O, Indridason OS et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005; 294: 2336-2341.
    • (2005) JAMA , vol.294 , pp. 2336-2341
    • Steingrimsdottir, L.1    Gunnarsson, O.2    Indridason, O.S.3
  • 40
    • 37849044276 scopus 로고    scopus 로고
    • Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake
    • Adami S, Viapiana O, Gatti D et al. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone 2008; 42: 267-270.
    • (2008) Bone , vol.42 , pp. 267-270
    • Adami, S.1    Viapiana, O.2    Gatti, D.3
  • 41
    • 23844489806 scopus 로고    scopus 로고
    • Vitamin D for health and in chronic kidney disease
    • Holick MF. Vitamin D for health and in chronic kidney disease. Semin Dial 2005; 18: 266-275.
    • (2005) Semin Dial , vol.18 , pp. 266-275
    • Holick, M.F.1
  • 42
    • 12944268318 scopus 로고    scopus 로고
    • Normal serum vitamin D levels
    • Hollis BW, Wagner CL. Normal serum vitamin D levels. N Engl J Med 2005; 352: 515-516.
    • (2005) N Engl J Med , vol.352 , pp. 515-516
    • Hollis, B.W.1    Wagner, C.L.2
  • 43
    • 42949091376 scopus 로고    scopus 로고
    • Vitamin D status and cancer incidence and mortality
    • Giovannucci E. Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol 2008; 624: 31-42.
    • (2008) Adv Exp Med Biol , vol.624 , pp. 31-42
    • Giovannucci, E.1
  • 44
    • 41949105851 scopus 로고    scopus 로고
    • Review: Vitamin D supplementation decreases all-cause mortality in adults and older people
    • Simon JA. Review: vitamin D supplementation decreases all-cause mortality in adults and older people. Evid Based Med 2008; 13: 47.
    • (2008) Evid Based Med , vol.13 , pp. 47
    • Simon, J.A.1
  • 45
    • 34948869354 scopus 로고    scopus 로고
    • Vitamin D levels and early mortality among incident hemodialysis patients
    • Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-1013.
    • (2007) Kidney Int , vol.72 , pp. 1004-1013
    • Wolf, M.1    Shah, A.2    Gutierrez, O.3
  • 46
    • 34250015299 scopus 로고    scopus 로고
    • Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial
    • Lappe JM, Travers-Gustafson D, Davies KM et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591.
    • (2007) Am J Clin Nutr , vol.85 , pp. 1586-1591
    • Lappe, J.M.1    Travers-Gustafson, D.2    Davies, K.M.3
  • 47
    • 10644280669 scopus 로고    scopus 로고
    • Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study
    • Gonzalez EA, Sachdeva A, Oliver DA et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-510.
    • (2004) Am J Nephrol , vol.24 , pp. 503-510
    • Gonzalez, E.A.1    Sachdeva, A.2    Oliver, D.A.3
  • 48
    • 20444428708 scopus 로고    scopus 로고
    • Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States
    • LaClair RE, Hellman RN, Karp SL et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 2005; 45: 1026-1033.
    • (2005) Am J Kidney Dis , vol.45 , pp. 1026-1033
    • LaClair, R.E.1    Hellman, R.N.2    Karp, S.L.3
  • 49
    • 41449084839 scopus 로고    scopus 로고
    • Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
    • Gutierrez OM, Isakova T, Andress DL et al. Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int 2008; 73: 956-962.
    • (2008) Kidney Int , vol.73 , pp. 956-962
    • Gutierrez, O.M.1    Isakova, T.2    Andress, D.L.3
  • 50
    • 17144367004 scopus 로고    scopus 로고
    • Do not be misguided by guidelines: The calcium x phosphate product can be a Trojan horse
    • Ketteler M, Brandenburg V, Jahnen-Dechent W et al. Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse. Nephrol Dial Transplant 2005; 20: 673-677.
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 673-677
    • Ketteler, M.1    Brandenburg, V.2    Jahnen-Dechent, W.3
  • 51
    • 34648834843 scopus 로고    scopus 로고
    • The fallacy of the calcium-phosphorus product
    • O'Neill WC. The fallacy of the calcium-phosphorus product. Kidney Int 2007; 72: 792-796.
    • (2007) Kidney Int , vol.72 , pp. 792-796
    • O'Neill, W.C.1
  • 52
    • 0023461898 scopus 로고
    • Bone and plasma calcium homeostasis
    • Parfitt AM. Bone and plasma calcium homeostasis. Bone 1987; 8 (Suppl 1): S1-8.
    • (1987) Bone , vol.8 , Issue.SUPPL. 1
    • Parfitt, A.M.1
  • 53
    • 49649118377 scopus 로고    scopus 로고
    • Pitfalls of measuring total blood calcium in patients with CKD
    • Gauci C, Moranne O, Fouqueray B et al. Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol 2008; 19: 1592-1598.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1592-1598
    • Gauci, C.1    Moranne, O.2    Fouqueray, B.3
  • 54
    • 67651113988 scopus 로고    scopus 로고
    • The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations
    • Labriola L, Wallemacq P, Gulbis B et al. The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations. Nephrol Dial Transplant 2009; 24: 1834-1838.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 1834-1838
    • Labriola, L.1    Wallemacq, P.2    Gulbis, B.3
  • 55
    • 0023576001 scopus 로고
    • Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D
    • Portale AA, Halloran BP, Morris Jr RC. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 1987; 80: 1147-1154.
    • (1987) J Clin Invest , vol.80 , pp. 1147-1154
    • Portale, A.A.1    Halloran, B.P.2    Morris Jr, R.C.3
  • 56
    • 60149109219 scopus 로고    scopus 로고
    • Serum phosphorus concentrations in the Third National Health and Nutrition Examination Survey (NHANES III)
    • de Boer IH, Rue TC, Kestenbaum B. Serum phosphorus concentrations in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2009; 53: 399-407.
    • (2009) Am J Kidney Dis , vol.53 , pp. 399-407
    • de Boer, I.H.1    Rue, T.C.2    Kestenbaum, B.3
  • 57
    • 33846188978 scopus 로고    scopus 로고
    • Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis
    • Worcester EM, Gillen DL, Evan AP et al. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol 2007; 292: F66-75.
    • (2007) Am J Physiol , vol.292
    • Worcester, E.M.1    Gillen, D.L.2    Evan, A.P.3
  • 58
    • 28244475974 scopus 로고    scopus 로고
    • Lack of significant circadian and post-prandial variation in phosphate levels in subjects receiving chronic hemodialysis therapy
    • Trivedi H, Moore H, Atalla J. Lack of significant circadian and post-prandial variation in phosphate levels in subjects receiving chronic hemodialysis therapy. J Nephrol 2005; 18: 417-422.
    • (2005) J Nephrol , vol.18 , pp. 417-422
    • Trivedi, H.1    Moore, H.2    Atalla, J.3
  • 59
    • 36849017126 scopus 로고    scopus 로고
    • The parathyroid is a target organ for FGF23 in rats
    • Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007; 117: 4003-4008.
    • (2007) J Clin Invest , vol.117 , pp. 4003-4008
    • Ben-Dov, I.Z.1    Galitzer, H.2    Lavi-Moshayoff, V.3
  • 60
    • 0031712434 scopus 로고    scopus 로고
    • Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism
    • Schmitt CP, Huber D, Mehls O et al. Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism. J Am Soc Nephrol 1998; 9: 1832-1844.
    • (1998) J Am Soc Nephrol , vol.9 , pp. 1832-1844
    • Schmitt, C.P.1    Huber, D.2    Mehls, O.3
  • 62
    • 13844319168 scopus 로고    scopus 로고
    • Evolution of the parathyroid hormone (PTH) assay-importance of circulating PTH immunoheterogeneity and of its regulation
    • Gao P, D'Amour P. Evolution of the parathyroid hormone (PTH) assay-importance of circulating PTH immunoheterogeneity and of its regulation. Clin lab 2005; 51: 21-29.
    • (2005) Clin lab , vol.51 , pp. 21-29
    • Gao, P.1    D'Amour, P.2
  • 63
    • 0033860423 scopus 로고    scopus 로고
    • A novel mechanism for skeletal resistance in uremia
    • Slatopolsky E, Finch J, Clay P et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000; 58: 753-761.
    • (2000) Kidney Int , vol.58 , pp. 753-761
    • Slatopolsky, E.1    Finch, J.2    Clay, P.3
  • 64
    • 0038057620 scopus 로고    scopus 로고
    • Parathyroid hormone assays-evolution and revolutions in the care of dialysis patients
    • Malluche HH, Mawad H, Trueba D et al. Parathyroid hormone assays-evolution and revolutions in the care of dialysis patients. Clin Nephrol 2003; 59: 313-318.
    • (2003) Clin Nephrol , vol.59 , pp. 313-318
    • Malluche, H.H.1    Mawad, H.2    Trueba, D.3
  • 65
    • 33745823912 scopus 로고    scopus 로고
    • Parathyroid hormone 7-84 induces hypocalcemia and inhibits the parathyroid hormone 1-84 secretory response to hypocalcemia in rats with intact parathyroid glands
    • Huan J, Olgaard K, Nielsen LB et al. Parathyroid hormone 7-84 induces hypocalcemia and inhibits the parathyroid hormone 1-84 secretory response to hypocalcemia in rats with intact parathyroid glands. J Am Soc Nephrol 2006; 17: 1923-1930.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 1923-1930
    • Huan, J.1    Olgaard, K.2    Nielsen, L.B.3
  • 67
    • 0036321071 scopus 로고    scopus 로고
    • PTH 1-84 and PTH '7-84' in the noninvasive diagnosis of renal bone disease
    • Coen G, Bonucci E, Ballanti P et al. PTH 1-84 and PTH '7-84' in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 2002; 40: 348-354.
    • (2002) Am J Kidney Dis , vol.40 , pp. 348-354
    • Coen, G.1    Bonucci, E.2    Ballanti, P.3
  • 68
    • 0037383752 scopus 로고    scopus 로고
    • Influence of PTH assay methodology on differential diagnosis of renal bone disease
    • Reichel H, Esser A, Roth H-J et al. Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 2003; 18: 759-768.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 759-768
    • Reichel, H.1    Esser, A.2    Roth, H.-J.3
  • 69
    • 0034791485 scopus 로고    scopus 로고
    • Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients
    • Monier-Faugere MC, Geng Z, Mawad H et al. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 2001; 60: 1460-1468.
    • (2001) Kidney Int , vol.60 , pp. 1460-1468
    • Monier-Faugere, M.C.1    Geng, Z.2    Mawad, H.3
  • 70
    • 68249151057 scopus 로고    scopus 로고
    • : Mineral bone disorders in chronic kidney disease
    • 8th edn. WB Saunders Company: Philadelphia, PA
    • Moe SM, Sprague SM. Chapter 52: Mineral bone disorders in chronic kidney disease. In: Brenner and Rector's The Kidney, 8th edn. WB Saunders Company: Philadelphia, PA, 2007, pp 1784-1807.
    • (2007) Brenner and Rector's The Kidney , pp. 1784-1807
    • Moe, S.M.1    Sprague, S.M.2
  • 71
    • 17744396468 scopus 로고    scopus 로고
    • Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients
    • Holmes DT, Levin A, Forer B et al. Preanalytical influences on DPC IMMULITE 2000 intact PTH assays of plasma and serum from dialysis patients. Clin Chem 2005; 51: 915-917.
    • (2005) Clin Chem , vol.51 , pp. 915-917
    • Holmes, D.T.1    Levin, A.2    Forer, B.3
  • 72
    • 44049098064 scopus 로고    scopus 로고
    • Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: A cross-sectional study
    • Joly D, Drueke TB, Alberti C et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. Am J Kidney Dis 2008; 51: 987-995.
    • (2008) Am J Kidney Dis , vol.51 , pp. 987-995
    • Joly, D.1    Drueke, T.B.2    Alberti, C.3
  • 73
    • 0022192485 scopus 로고
    • Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status
    • Hollis BW, Napoli JL. Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem 1985; 31: 1815-1819.
    • (1985) Clin Chem , vol.31 , pp. 1815-1819
    • Hollis, B.W.1    Napoli, J.L.2
  • 74
    • 4444286686 scopus 로고    scopus 로고
    • Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer
    • Ersfeld DL, Rao DS, Body JJ et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 2004; 37: 867-874.
    • (2004) Clin Biochem , vol.37 , pp. 867-874
    • Ersfeld, D.L.1    Rao, D.S.2    Body, J.J.3
  • 75
    • 33744494040 scopus 로고    scopus 로고
    • Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency
    • Saenger AK, Laha TJ, Bremner DE et al. Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency. Am J Clin Pathol 2006; 125: 914-920.
    • (2006) Am J Clin Pathol , vol.125 , pp. 914-920
    • Saenger, A.K.1    Laha, T.J.2    Bremner, D.E.3
  • 76
    • 18144364293 scopus 로고    scopus 로고
    • Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatographytandem mass spectrometry
    • Tsugawa N, Suhara Y, Kamao M et al. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatographytandem mass spectrometry. Anal Chem 2005; 77: 3001-3007.
    • (2005) Anal Chem , vol.77 , pp. 3001-3007
    • Tsugawa, N.1    Suhara, Y.2    Kamao, M.3
  • 77
    • 3242677654 scopus 로고    scopus 로고
    • Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task
    • Hollis BW. Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab 2004; 89: 3149-3151.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 3149-3151
    • Hollis, B.W.1
  • 78
    • 40849085157 scopus 로고    scopus 로고
    • Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D
    • Holick MF, Biancuzzo RM, Chen TC et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-681.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 677-681
    • Holick, M.F.1    Biancuzzo, R.M.2    Chen, T.C.3
  • 79
    • 43249122317 scopus 로고    scopus 로고
    • Correlation among 25-hydroxy-vitamin D assays
    • Binkley N, Krueger D, Gemar D et al. Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 2008; 93: 1804-1808.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 1804-1808
    • Binkley, N.1    Krueger, D.2    Gemar, D.3
  • 80
    • 85205860319 scopus 로고    scopus 로고
    • Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol 2005; 289: F8-28
    • Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol 2005; 289: F8-28.
  • 81
    • 0013878331 scopus 로고
    • Hemodialysis: A successful therapy for chronic uremia
    • Pendras JP, Erickson RV. Hemodialysis: a successful therapy for chronic uremia. Ann Intern Med 1966; 64: 293-311.
    • (1966) Ann Intern Med , vol.64 , pp. 293-311
    • Pendras, J.P.1    Erickson, R.V.2
  • 82
    • 0033920728 scopus 로고    scopus 로고
    • Increased risk of hip fracture among patients with end-stage renal disease
    • Alem AM, Sherrard DJ, Gillen DL et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000; 58: 396-399.
    • (2000) Kidney Int , vol.58 , pp. 396-399
    • Alem, A.M.1    Sherrard, D.J.2    Gillen, D.L.3
  • 83
    • 21844431862 scopus 로고    scopus 로고
    • Prognostic utility of a semiquantitative spinal deformity index
    • Crans GG, Genant HK, Krege JH. Prognostic utility of a semiquantitative spinal deformity index. Bone 2005; 37: 175-179.
    • (2005) Bone , vol.37 , pp. 175-179
    • Crans, G.G.1    Genant, H.K.2    Krege, J.H.3
  • 84
    • 0034022318 scopus 로고    scopus 로고
    • Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis
    • Klotzbuecher CM, Ross PD, Landsman PB et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721-739.
    • (2000) J Bone Miner Res , vol.15 , pp. 721-739
    • Klotzbuecher, C.M.1    Ross, P.D.2    Landsman, P.B.3
  • 85
    • 0035900949 scopus 로고    scopus 로고
    • Risk of new vertebral fracture in the year following a fracture
    • Lindsay R, Silverman SL, Cooper C et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001; 285: 320-323.
    • (2001) JAMA , vol.285 , pp. 320-323
    • Lindsay, R.1    Silverman, S.L.2    Cooper, C.3
  • 86
    • 33749192911 scopus 로고    scopus 로고
    • The effect of alendronate therapy on osteoporotic fracture in the vertebral fracture arm of the Fracture Intervention Trial
    • Black DM, Thompson DE. The effect of alendronate therapy on osteoporotic fracture in the vertebral fracture arm of the Fracture Intervention Trial. Int J Clin Pract 1999; 101 (Suppl): 46-50.
    • (1999) Int J Clin Pract , vol.101 , Issue.SUPPL. , pp. 46-50
    • Black, D.M.1    Thompson, D.E.2
  • 88
    • 0032524460 scopus 로고    scopus 로고
    • The association of radiographically detected vertebral fractures with back pain and function: A prospective study
    • Nevitt MC, Ettinger B, Black DM et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998; 128: 793-800.
    • (1998) Ann Intern Med , vol.128 , pp. 793-800
    • Nevitt, M.C.1    Ettinger, B.2    Black, D.M.3
  • 89
    • 29244440848 scopus 로고    scopus 로고
    • PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis
    • Danese MD, Kim J, Doan QV et al. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 2006; 47: 149-156.
    • (2006) Am J Kidney Dis , vol.47 , pp. 149-156
    • Danese, M.D.1    Kim, J.2    Doan, Q.V.3
  • 90
    • 0033659563 scopus 로고    scopus 로고
    • Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
    • Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000; 36: 1115-1121.
    • (2000) Am J Kidney Dis , vol.36 , pp. 1115-1121
    • Coco, M.1    Rush, H.2
  • 91
    • 4544229212 scopus 로고    scopus 로고
    • Increased risk of mortality associated with hip fracture in the dialysis population
    • Mittalhenkle A, Gillen DL, Stehman-Breen CO. Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 2004; 44: 672-679.
    • (2004) Am J Kidney Dis , vol.44 , pp. 672-679
    • Mittalhenkle, A.1    Gillen, D.L.2    Stehman-Breen, C.O.3
  • 92
    • 34147123148 scopus 로고    scopus 로고
    • Clinical epidemiology of longbone fractures in patients receiving hemodialysis
    • Kaneko TM, Foley RN, Gilbertson DT et al. Clinical epidemiology of longbone fractures in patients receiving hemodialysis. Clin Orthop Relat Res 2007; 457: 188-193.
    • (2007) Clin Orthop Relat Res , vol.457 , pp. 188-193
    • Kaneko, T.M.1    Foley, R.N.2    Gilbertson, D.T.3
  • 93
    • 0021968162 scopus 로고
    • Studies of bone morphology, bone densitometry, and laboratory data in patients on maintenance hemodialysis treatment
    • Lindergard B Johnell O, Nilsson BE. Studies of bone morphology, bone densitometry, and laboratory data in patients on maintenance hemodialysis treatment. Nephron 1985; 39: 122-129.
    • (1985) Nephron , vol.39 , pp. 122-129
    • Lindergard, B.1    Johnell, O.2    Nilsson, B.E.3
  • 94
    • 34548330007 scopus 로고    scopus 로고
    • Bone mineral density and bone histomorphometry in children on long-term dialysis
    • Andrade MC, Carvalhaes JT, Carvalho AB et al. Bone mineral density and bone histomorphometry in children on long-term dialysis. Pediatr Nephrol 2007; 22: 1767-1772.
    • (2007) Pediatr Nephrol , vol.22 , pp. 1767-1772
    • Andrade, M.C.1    Carvalhaes, J.T.2    Carvalho, A.B.3
  • 95
    • 0033884012 scopus 로고    scopus 로고
    • Bone biopsy results and serum bone turnover parameters in uremic children
    • Ziolkowska H, Paniczyk-Tomaszewska M, Debinski A et al. Bone biopsy results and serum bone turnover parameters in uremic children. Acta Paediatr 2000; 89: 666-671.
    • (2000) Acta Paediatr , vol.89 , pp. 666-671
    • Ziolkowska, H.1    Paniczyk-Tomaszewska, M.2    Debinski, A.3
  • 96
    • 0034051077 scopus 로고    scopus 로고
    • Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis
    • Yalcinkaya F, Ince E, Tumer N et al. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis. Pediatr Int 2000; 42: 53-57.
    • (2000) Pediatr Int , vol.42 , pp. 53-57
    • Yalcinkaya, F.1    Ince, E.2    Tumer, N.3
  • 97
    • 0028837248 scopus 로고
    • Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure
    • Hamdy NA, Kanis JA, Beneton MN et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 1995; 310: 358-363.
    • (1995) BMJ , vol.310 , pp. 358-363
    • Hamdy, N.A.1    Kanis, J.A.2    Beneton, M.N.3
  • 98
    • 33748040071 scopus 로고    scopus 로고
    • Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up
    • Spasovski GB, Sikole A, Gelev S et al. Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrol Dial Transplant 2006; 21: 2217-2224.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 2217-2224
    • Spasovski, G.B.1    Sikole, A.2    Gelev, S.3
  • 99
    • 0027978111 scopus 로고
    • Osteocalcin: A non-invasive index of metabolic bone disease in patients treated by CAPD
    • Joffe P, Heaf JG, Hyldstrup L. Osteocalcin: a non-invasive index of metabolic bone disease in patients treated by CAPD. Kidney Int 1994; 46: 838-846.
    • (1994) Kidney Int , vol.46 , pp. 838-846
    • Joffe, P.1    Heaf, J.G.2    Hyldstrup, L.3
  • 100
    • 2942737095 scopus 로고    scopus 로고
    • Low vs standard calcium dialysate in peritoneal dialysis: Differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study
    • Sanchez C, Lopez-Barea F, Sanchez-Cabezudo J et al. Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study. Nephrol Dial Transplant 2004; 19: 1587-1593.
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 1587-1593
    • Sanchez, C.1    Lopez-Barea, F.2    Sanchez-Cabezudo, J.3
  • 101
    • 0022549058 scopus 로고
    • Controlled trial of calcitriol in hemodialysis patients
    • Baker LR, Muir JW, Sharman VL et al. Controlled trial of calcitriol in hemodialysis patients. Clin Nephrol 1986; 26: 185-191.
    • (1986) Clin Nephrol , vol.26 , pp. 185-191
    • Baker, L.R.1    Muir, J.W.2    Sharman, V.L.3
  • 102
    • 0023698497 scopus 로고
    • Low dose calcitriol versus placebo in patients with predialysis chronic renal failure
    • Nordal KP, Dahl E. Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. J Clin Endocrinol Metab 1988; 67: 929-936.
    • (1988) J Clin Endocrinol Metab , vol.67 , pp. 929-936
    • Nordal, K.P.1    Dahl, E.2
  • 103
    • 54949133635 scopus 로고    scopus 로고
    • Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years
    • Malluche HH, Siami GA, Swanepoel C et al. Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years. Clin Nephrol 2008; 70: 284-295.
    • (2008) Clin Nephrol , vol.70 , pp. 284-295
    • Malluche, H.H.1    Siami, G.A.2    Swanepoel, C.3
  • 104
    • 39049125268 scopus 로고    scopus 로고
    • Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients
    • Ferreira A, Frazao JM, Monier-Faugere MC et al. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol 2008; 19: 405-412.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 405-412
    • Ferreira, A.1    Frazao, J.M.2    Monier-Faugere, M.C.3
  • 105
    • 85047697721 scopus 로고
    • Adynamic bone disease with negative aluminium staining in predialysis patients: Prevalence and evolution after maintenance dialysis
    • Hernandez D, Concepcion MT, Lorenzo V et al. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis. Nephrol Dial Transplant 1994; 9: 517-523.
    • (1994) Nephrol Dial Transplant , vol.9 , pp. 517-523
    • Hernandez, D.1    Concepcion, M.T.2    Lorenzo, V.3
  • 106
    • 0033381472 scopus 로고    scopus 로고
    • Renal osteodystrophy in pre-dialysis patients: Ethnic difference?
    • Shin SK, Kim DH, Kim HS et al. Renal osteodystrophy in pre-dialysis patients: ethnic difference? Perit Dial Int 1999; 19 (Suppl 2): S402-407.
    • (1999) Perit Dial Int , vol.19 , Issue.SUPPL. 2
    • Shin, S.K.1    Kim, D.H.2    Kim, H.S.3
  • 107
    • 0037670176 scopus 로고    scopus 로고
    • Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis
    • Spasovski GB, Bervoets AR, Behets GJ et al. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant 2003; 18: 1159-1166.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 1159-1166
    • Spasovski, G.B.1    Bervoets, A.R.2    Behets, G.J.3
  • 108
    • 18344392061 scopus 로고    scopus 로고
    • Renal osteodystrophy in predialysis and hemodialysis patients: Comparison of histologic patterns and diagnostic predictivity of intact PTH
    • Coen G, Ballanti P, Bonucci E et al. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron 2002; 91: 103-111.
    • (2002) Nephron , vol.91 , pp. 103-111
    • Coen, G.1    Ballanti, P.2    Bonucci, E.3
  • 109
    • 0034297978 scopus 로고    scopus 로고
    • Renal osteodystrophy in Ramathibodi Hospital: Histomorphometry and clinical correlation
    • Changsirikulchai S, Domrong kitchaiporn S, Sirikulchayanonta V et al. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation. J Med Assoc Thai 2000; 83: 1223-1232.
    • (2000) J Med Assoc Thai , vol.83 , pp. 1223-1232
    • Changsirikulchai, S.1    Domrong kitchaiporn, S.2    Sirikulchayanonta, V.3
  • 110
    • 10744220420 scopus 로고    scopus 로고
    • Serum leptin in dialysis renal osteodystrophy
    • Coen G, Ballanti P, Fischer MS et al. Serum leptin in dialysis renal osteodystrophy. Am J Kidney Dis 2003; 42: 1036-1042.
    • (2003) Am J Kidney Dis , vol.42 , pp. 1036-1042
    • Coen, G.1    Ballanti, P.2    Fischer, M.S.3
  • 111
  • 112
    • 0029872374 scopus 로고    scopus 로고
    • Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study
    • Coen G, Mazzaferro S, Ballanti P et al. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 1996; 11: 813-819.
    • (1996) Nephrol Dial Transplant , vol.11 , pp. 813-819
    • Coen, G.1    Mazzaferro, S.2    Ballanti, P.3
  • 113
    • 0023762660 scopus 로고
    • Fractures and vertebral bone mineral density in patients with renal osteodystrophy
    • Piraino B, Chen T, Cooperstein L et al. Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 1988; 30: 57-62.
    • (1988) Clin Nephrol , vol.30 , pp. 57-62
    • Piraino, B.1    Chen, T.2    Cooperstein, L.3
  • 114
    • 0038526468 scopus 로고    scopus 로고
    • The renal osteodystrophy pattern in Brazil and Uruguay: An overview
    • Araujo SM, Ambrosoni P, Lobao RR et al. The renal osteodystrophy pattern in Brazil and Uruguay: an overview. Kidney Int 2003; 63 (Suppl 85): S54-56.
    • (2003) Kidney Int , vol.63 , Issue.SUPPL. 85
    • Araujo, S.M.1    Ambrosoni, P.2    Lobao, R.R.3
  • 115
    • 0034529558 scopus 로고    scopus 로고
    • Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis
    • Gerakis A, Hadjidakis D, Kokkinakis E et al. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 2000; 13: 437-443.
    • (2000) J Nephrol , vol.13 , pp. 437-443
    • Gerakis, A.1    Hadjidakis, D.2    Kokkinakis, E.3
  • 116
    • 3042528668 scopus 로고    scopus 로고
    • Arterial calcifications and bone histomorphometry in end-stage renal disease
    • London GM, Marty C, Marchais SJ et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004; 15: 1943-1951.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 1943-1951
    • London, G.M.1    Marty, C.2    Marchais, S.J.3
  • 117
    • 54749090958 scopus 로고    scopus 로고
    • Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD
    • London GM, Marchais SJ, Guerin AP et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008; 19: 1827-1835.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1827-1835
    • London, G.M.1    Marchais, S.J.2    Guerin, A.P.3
  • 118
    • 20144387317 scopus 로고    scopus 로고
    • Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
    • Barreto DV, Barreto FC, Carvalho AB et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int 2005; 67: 1576-1582.
    • (2005) Kidney Int , vol.67 , pp. 1576-1582
    • Barreto, D.V.1    Barreto, F.C.2    Carvalho, A.B.3
  • 119
    • 56049127121 scopus 로고    scopus 로고
    • Association of changes in bone remodeling and coronary calcification in hemodialysis patients: A prospective study
    • Barreto DV, Barreto Fde C, Carvalho AB et al. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis 2008; 52: 1139-1150.
    • (2008) Am J Kidney Dis , vol.52 , pp. 1139-1150
    • Barreto, D.V.1    Barreto Fde, C.2    Carvalho, A.B.3
  • 120
    • 34247529494 scopus 로고    scopus 로고
    • Low bone mineral density and fractures in long-term hemodialysis patients: A meta-analysis
    • Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 2007; 49: 674-681.
    • (2007) Am J Kidney Dis , vol.49 , pp. 674-681
    • Jamal, S.A.1    Hayden, J.A.2    Beyene, J.3
  • 121
    • 0023358909 scopus 로고
    • The proportion of trabecular bone in human vertebrae
    • Nottestad SY, Baumel JJ, Kimmel DB et al. The proportion of trabecular bone in human vertebrae. J Bone Miner Res 1987; 2: 221-229.
    • (1987) J Bone Miner Res , vol.2 , pp. 221-229
    • Nottestad, S.Y.1    Baumel, J.J.2    Kimmel, D.B.3
  • 122
    • 0042026882 scopus 로고    scopus 로고
    • Relationship between age, renal function and bone mineral density in the US population
    • Klawansky S, Komaroff E, Cavanaugh Jr PF et al. Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 2003; 14: 570-576.
    • (2003) Osteoporos Int , vol.14 , pp. 570-576
    • Klawansky, S.1    Komaroff, E.2    Cavanaugh Jr, P.F.3
  • 123
    • 43549090868 scopus 로고    scopus 로고
    • Prevalence of chronic kidney disease in population-based studies: Systematic review
    • Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117.
    • (2008) BMC Public Health , vol.8 , pp. 117
    • Zhang, Q.L.1    Rothenbacher, D.2
  • 124
    • 33846527154 scopus 로고    scopus 로고
    • Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: The Rancho Bernardo study
    • Jassal SK, von Muhlen D, Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 2007; 22: 203-210.
    • (2007) J Bone Miner Res , vol.22 , pp. 203-210
    • Jassal, S.K.1    von Muhlen, D.2    Barrett-Connor, E.3
  • 125
    • 0035837553 scopus 로고    scopus 로고
    • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
    • Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-1441.
    • (2001) N Engl J Med , vol.344 , pp. 1434-1441
    • Neer, R.M.1    Arnaud, C.D.2    Zanchetta, J.R.3
  • 126
    • 28144453342 scopus 로고    scopus 로고
    • Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: A pooled analysis of nine clinical trials
    • Miller PD, Roux C, Boonen S et al. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 2005; 20: 2105-2115.
    • (2005) J Bone Miner Res , vol.20 , pp. 2105-2115
    • Miller, P.D.1    Roux, C.2    Boonen, S.3
  • 127
    • 34249653663 scopus 로고    scopus 로고
    • Alendronate treatment in women with normal to severely impaired renal function: An analysis of the Fracture Intervention Trial
    • Jamal SA, Bauer DC, Ensrud KE et al. Alendronate treatment in women with normal to severely impaired renal function: an analysis of the Fracture Intervention Trial. J Bone Miner Res 2007; 22: 503-508.
    • (2007) J Bone Miner Res , vol.22 , pp. 503-508
    • Jamal, S.A.1    Bauer, D.C.2    Ensrud, K.E.3
  • 128
    • 0015356713 scopus 로고
    • Determination of body composition by neutron activation analysis in patient with renal failure
    • Cohn SH, Cinque TJ, Dombrowski CS et al. Determination of body composition by neutron activation analysis in patient with renal failure. J Lab Clin Med 1972; 79: 978-994.
    • (1972) J Lab Clin Med , vol.79 , pp. 978-994
    • Cohn, S.H.1    Cinque, T.J.2    Dombrowski, C.S.3
  • 129
    • 0015856804 scopus 로고
    • The use of photon absorptiometry in the diagnosis of renal osteodystrophy
    • Griffiths HJ, Zimmerman RE, Bailey G et al. The use of photon absorptiometry in the diagnosis of renal osteodystrophy. Radiology 1973; 109: 277-281.
    • (1973) Radiology , vol.109 , pp. 277-281
    • Griffiths, H.J.1    Zimmerman, R.E.2    Bailey, G.3
  • 130
    • 0016714013 scopus 로고
    • Correlation of radial bone mineral content with total body calcium in chronic renal failure
    • Cohn SH, Ellis KJ, Caselnova RC et al. Correlation of radial bone mineral content with total body calcium in chronic renal failure. J Lab Clin Med 1975; 86: 910-919.
    • (1975) J Lab Clin Med , vol.86 , pp. 910-919
    • Cohn, S.H.1    Ellis, K.J.2    Caselnova, R.C.3
  • 131
    • 0016968569 scopus 로고
    • The effect of chronic renal failure and maintenance hemodialysis on bone mineral content of the radius
    • Parfitt AM, Oliver I, Walczak N et al. The effect of chronic renal failure and maintenance hemodialysis on bone mineral content of the radius. AJR Am J Roentgenol 1976; 126: 1292-1293.
    • (1976) AJR Am J Roentgenol , vol.126 , pp. 1292-1293
    • Parfitt, A.M.1    Oliver, I.2    Walczak, N.3
  • 132
  • 133
    • 67650724585 scopus 로고
    • Photon absorptiometry in hemodialysis and transplant patients in Newcastle upon Tyne, England
    • Mazess RB ed, Ontario, Canada, Published by US Department of Health and Human Services, Bethesda, MD, NIH Publication No. 80-1938
    • Aird EGA, Peerides AM. Photon absorptiometry in hemodialysis and transplant patients in Newcastle upon Tyne, England. In: Mazess RB (ed) Proceedings of the Fourth International Conference on Bone Measurement, Ontario, Canada, 1978. Published by US Department of Health and Human Services, Bethesda, MD, NIH Publication No. 80-1938, 1980, pp 217-230.
    • (1978) Proceedings of the Fourth International Conference on Bone Measurement , pp. 217-230
    • Aird, E.G.A.1    Peerides, A.M.2
  • 134
    • 67650728429 scopus 로고
    • Bone mineral content of patients on hemodialysis and following renal transplantation
    • Mazess RB ed, Ontario, Canada, Published by US Department of Health and Human Services, Bethesda, MD, NIH Publication No. 80-1938
    • Bailey RR, Stokes A, Mazess R. Bone mineral content of patients on hemodialysis and following renal transplantation. In: Mazess RB (ed) Proceedings of the Fourth International Conference on Bone Measurement, Ontario, Canada, 1978. Published by US Department of Health and Human Services, Bethesda, MD, NIH Publication No. 80-1938, 1980, pp 211-216.
    • (1978) Proceedings of the Fourth International Conference on Bone Measurement , pp. 211-216
    • Bailey, R.R.1    Stokes, A.2    Mazess, R.3
  • 135
    • 0020562818 scopus 로고
    • Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients
    • Heaf JG, Nielsen LP, Mogensen NB. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients. Nephron 1983; 35: 103-107.
    • (1983) Nephron , vol.35 , pp. 103-107
    • Heaf, J.G.1    Nielsen, L.P.2    Mogensen, N.B.3
  • 136
    • 0021029112 scopus 로고
    • Bone mineral content in patients on prolonged maintenance hemodialysis: A three year follow-up study
    • Rickers H, Christensen M, Rodbro P. Bone mineral content in patients on prolonged maintenance hemodialysis: a three year follow-up study. Clin Nephrol 1983; 20: 302-307.
    • (1983) Clin Nephrol , vol.20 , pp. 302-307
    • Rickers, H.1    Christensen, M.2    Rodbro, P.3
  • 137
    • 0021826485 scopus 로고
    • Changes in total body calcium after renal transplantation: Effect of low-dose steroid regime
    • Eastell R, Kennedy NSJ, Smith MA et al. Changes in total body calcium after renal transplantation: effect of low-dose steroid regime. Nephron 1985; 40: 139-142.
    • (1985) Nephron , vol.40 , pp. 139-142
    • Eastell, R.1    Kennedy, N.S.J.2    Smith, M.A.3
  • 138
    • 0021968162 scopus 로고
    • Studies of bone morphology, bone densitometry, and laboratory data in patients on maintenance hemodialysis treatment
    • Lindergard B, Johnell O, Nilsson BE et al. Studies of bone morphology, bone densitometry, and laboratory data in patients on maintenance hemodialysis treatment. Nephron 1985; 39: 122-129.
    • (1985) Nephron , vol.39 , pp. 122-129
    • Lindergard, B.1    Johnell, O.2    Nilsson, B.E.3
  • 139
    • 0021953908 scopus 로고
    • Deranged mineral content in the bone of patients with chronic renal failure, estimated by computed tomography
    • Marumo F, Sakurai K, Sato N et al. Deranged mineral content in the bone of patients with chronic renal failure, estimated by computed tomography. Int J Artif Organs 1985; 8: 95-100.
    • (1985) Int J Artif Organs , vol.8 , pp. 95-100
    • Marumo, F.1    Sakurai, K.2    Sato, N.3
  • 140
    • 0021971992 scopus 로고
    • Calcium balance in uremia: Longitudinal study of long-term survivors
    • Schuster VL, Chesnut CH, Baylink DJ et al. Calcium balance in uremia: longitudinal study of long-term survivors. Nephron 1985; 41: 132-140.
    • (1985) Nephron , vol.41 , pp. 132-140
    • Schuster, V.L.1    Chesnut, C.H.2    Baylink, D.J.3
  • 141
    • 0024311291 scopus 로고
    • Monitoring of bone mineral content in patients on regular hemodialysis
    • Eeckhout E, Verbeelen D, Sennesael J et al. Monitoring of bone mineral content in patients on regular hemodialysis. Nephron 1989; 52: 158-161.
    • (1989) Nephron , vol.52 , pp. 158-161
    • Eeckhout, E.1    Verbeelen, D.2    Sennesael, J.3
  • 142
    • 0025788833 scopus 로고
    • Rapid loss of vertebral mineral density after renal transplantation
    • Julian BA, Laskow DA, Dubovsky J et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544-550.
    • (1991) N Engl J Med , vol.325 , pp. 544-550
    • Julian, B.A.1    Laskow, D.A.2    Dubovsky, J.3
  • 143
    • 0026688260 scopus 로고
    • Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis
    • Asaka M, LIida H, Entani C et al. Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clin Nephrol 1992; 38: 149-153.
    • (1992) Clin Nephrol , vol.38 , pp. 149-153
    • Asaka, M.1    LIida, H.2    Entani, C.3
  • 144
    • 0026720479 scopus 로고
    • Total and regional bone densities in dialysis patients
    • Chan TM, Pun KK, Cheng IK. Total and regional bone densities in dialysis patients. Nephrol Dial Transplant 1992; 7: 835-839.
    • (1992) Nephrol Dial Transplant , vol.7 , pp. 835-839
    • Chan, T.M.1    Pun, K.K.2    Cheng, I.K.3
  • 145
    • 0027165489 scopus 로고
    • Bone mineral density in patients with end-stage renal failure
    • Gabay C, Ruedin P, Slosman D et al. Bone mineral density in patients with end-stage renal failure. Am J Nephrol 1993; 13: 115-123.
    • (1993) Am J Nephrol , vol.13 , pp. 115-123
    • Gabay, C.1    Ruedin, P.2    Slosman, D.3
  • 146
    • 0027496973 scopus 로고
    • Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease
    • Hutchison AJ, Whitehouse RW, Boulton HF et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071-1077.
    • (1993) Kidney Int , vol.44 , pp. 1071-1077
    • Hutchison, A.J.1    Whitehouse, R.W.2    Boulton, H.F.3
  • 147
    • 0027417763 scopus 로고
    • Long-term outcome following total parathyroidectomy in patients with end-stage renal disease
    • Kaye M, Rosenthall L, Hill RO et al. Long-term outcome following total parathyroidectomy in patients with end-stage renal disease. Clin Nephrol 1993; 39: 192-197.
    • (1993) Clin Nephrol , vol.39 , pp. 192-197
    • Kaye, M.1    Rosenthall, L.2    Hill, R.O.3
  • 148
    • 0027209898 scopus 로고
    • Maintenance of bone mass in patients receiving dialytic therapy
    • Moe SM, Yu BO, Sprague SM. Maintenance of bone mass in patients receiving dialytic therapy. Am J Kidney Dis 1993; 22: 300-307.
    • (1993) Am J Kidney Dis , vol.22 , pp. 300-307
    • Moe, S.M.1    Yu, B.O.2    Sprague, S.M.3
  • 149
    • 0028229884 scopus 로고
    • Bone mineral densitometry in dialyzed patients: Quantitative computed tomography versus dual photon absorptiometry
    • Lechleitner P, Krimbacker E, Genser N et al. Bone mineral densitometry in dialyzed patients: quantitative computed tomography versus dual photon absorptiometry. Bone 1994; 15: 387-391.
    • (1994) Bone , vol.15 , pp. 387-391
    • Lechleitner, P.1    Krimbacker, E.2    Genser, N.3
  • 150
    • 0027958437 scopus 로고
    • Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure
    • Ruedin P, Rizzoli R, Slosman D et al. Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure. Kidney Int 1994; 45: 245-252.
    • (1994) Kidney Int , vol.45 , pp. 245-252
    • Ruedin, P.1    Rizzoli, R.2    Slosman, D.3
  • 151
    • 0030022865 scopus 로고    scopus 로고
    • Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis
    • Mottet JJ, Horber FF, Casez JP et al. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. J Bone Miner Res 1996; 11: 96-104.
    • (1996) J Bone Miner Res , vol.11 , pp. 96-104
    • Mottet, J.J.1    Horber, F.F.2    Casez, J.P.3
  • 152
    • 0029795843 scopus 로고    scopus 로고
    • Prevalence and risk factors for osteopenia in dialysis patients
    • Stein MS, Packham DK, Ebeling PR et al. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 1996; 28: 515-522.
    • (1996) Am J Kidney Dis , vol.28 , pp. 515-522
    • Stein, M.S.1    Packham, D.K.2    Ebeling, P.R.3
  • 153
    • 0029856258 scopus 로고    scopus 로고
    • Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures
    • Yamaguchi T, Kanno E, Tsubota J et al. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 1996; 19: 549-555.
    • (1996) Bone , vol.19 , pp. 549-555
    • Yamaguchi, T.1    Kanno, E.2    Tsubota, J.3
  • 154
    • 0031030406 scopus 로고    scopus 로고
    • Muscular strength and bone mineral density in haemodialysis patients
    • Spindler A, Paz S, Berman A et al. Muscular strength and bone mineral density in haemodialysis patients. Nephrol Dial Transplant 1997; 12: 128-132.
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 128-132
    • Spindler, A.1    Paz, S.2    Berman, A.3
  • 155
    • 0031732356 scopus 로고    scopus 로고
    • Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: A randomized, double blind study in kidney transplant patients
    • Lippuner K, Casez JP, Horber FF et al. Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients. J Clin Endocrinol Metab 1998; 83: 3795-3802.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 3795-3802
    • Lippuner, K.1    Casez, J.P.2    Horber, F.F.3
  • 156
    • 0031763530 scopus 로고    scopus 로고
    • Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis
    • Russo CR, Taccetti G, Caneva P et al. Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos Int 1998; 8: 443-448.
    • (1998) Osteoporos Int , vol.8 , pp. 443-448
    • Russo, C.R.1    Taccetti, G.2    Caneva, P.3
  • 157
    • 0032966126 scopus 로고    scopus 로고
    • Risk factors for vertebral fractures in renal osteodystrophy
    • Atsumi K, Kushida K, Yamazaki K et al. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 1999; 33: 287-293.
    • (1999) Am J Kidney Dis , vol.33 , pp. 287-293
    • Atsumi, K.1    Kushida, K.2    Yamazaki, K.3
  • 158
    • 0032938413 scopus 로고    scopus 로고
    • Racial differences in bone mineral density and bone loss among end-stage renal disease patients
    • Stehman-Breen CO, Sherrard D, Walker A et al. Racial differences in bone mineral density and bone loss among end-stage renal disease patients. Am J Kidney Dis 1999; 33: 941-946.
    • (1999) Am J Kidney Dis , vol.33 , pp. 941-946
    • Stehman-Breen, C.O.1    Sherrard, D.2    Walker, A.3
  • 159
    • 0032809985 scopus 로고    scopus 로고
    • Risk factors for reduced bone density in haemodialysis patients
    • Taal MW, Masud T, Green D et al. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 1999; 14: 1922-1928.
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 1922-1928
    • Taal, M.W.1    Masud, T.2    Green, D.3
  • 160
    • 0033755902 scopus 로고    scopus 로고
    • Bone mineral density in haemodialysis patients: A comparative study of dual-energy X-ray absorptiometry and quantitative ultrasound
    • Arici M, Erturk H, Altun B et al. Bone mineral density in haemodialysis patients: a comparative study of dual-energy X-ray absorptiometry and quantitative ultrasound. Nephrol Dial Transplant 2000; 15: 1847-1851.
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 1847-1851
    • Arici, M.1    Erturk, H.2    Altun, B.3
  • 161
    • 0033932903 scopus 로고    scopus 로고
    • Pamidronate therapy as prevention of bone loss following renal transplantation
    • Fan SL, Almond MK, Ball E et al. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 2000; 57: 684-690.
    • (2000) Kidney Int , vol.57 , pp. 684-690
    • Fan, S.L.1    Almond, M.K.2    Ball, E.3
  • 162
    • 0000085057 scopus 로고    scopus 로고
    • Factors influencing vertebral bone density after renal transplantation
    • Kokado Y, Takahara S, Ichimaru N et al. Factors influencing vertebral bone density after renal transplantation. Transpl Int 2000; 13 (Suppl 1): S431-435.
    • (2000) Transpl Int , vol.13 , Issue.SUPPL. 1
    • Kokado, Y.1    Takahara, S.2    Ichimaru, N.3
  • 163
    • 0034995059 scopus 로고    scopus 로고
    • A comparison of quantitative computed tomography and dual X-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis
    • Barnas U, Schmidt A, Seidl G et al. A comparison of quantitative computed tomography and dual X-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis. Am J Kidney Dis 2001; 37: 1247-1252.
    • (2001) Am J Kidney Dis , vol.37 , pp. 1247-1252
    • Barnas, U.1    Schmidt, A.2    Seidl, G.3
  • 164
    • 0035233281 scopus 로고    scopus 로고
    • Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis
    • Baszko-Blaszyk D, Grzegorzewska AE, Horst-Sikorska W et al. Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis. Adv Perit Dial 2001; 17: 109-113.
    • (2001) Adv Perit Dial , vol.17 , pp. 109-113
    • Baszko-Blaszyk, D.1    Grzegorzewska, A.E.2    Horst-Sikorska, W.3
  • 165
    • 0034921633 scopus 로고    scopus 로고
    • Effect of ibandronate on bone loss and renal function after kidney transplantation
    • Grotz W, Nagel C, Poeschel D et al. Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 2001; 12: 1530-1537.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 1530-1537
    • Grotz, W.1    Nagel, C.2    Poeschel, D.3
  • 166
    • 0036020931 scopus 로고    scopus 로고
    • Changes in bone mineral density over 18 months following kidney transplantation: The respective roles of prednisone and parathyroid hormone
    • Casez JP, Lippuner K, Horber FF et al. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone. Nephrol Dial Transplant 2002; 17: 1318-1326.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1318-1326
    • Casez, J.P.1    Lippuner, K.2    Horber, F.F.3
  • 167
    • 0036189082 scopus 로고    scopus 로고
    • Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients
    • Haas M, Leko-Mohr Z, Roschger P et al. Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients. Am J Kidney Dis 2002; 39: 580-586.
    • (2002) Am J Kidney Dis , vol.39 , pp. 580-586
    • Haas, M.1    Leko-Mohr, Z.2    Roschger, P.3
  • 168
    • 0036092295 scopus 로고    scopus 로고
    • Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis
    • Hampson G, Vaja S, Evans C et al. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephron 2002; 91: 94-102.
    • (2002) Nephron , vol.91 , pp. 94-102
    • Hampson, G.1    Vaja, S.2    Evans, C.3
  • 169
    • 0036044617 scopus 로고    scopus 로고
    • Risk factors for hip fracture in hemodialysis patients
    • Kaji H, Suzuki M, Yano S et al. Risk factors for hip fracture in hemodialysis patients. Am J Nephrol 2002; 22: 325-331.
    • (2002) Am J Nephrol , vol.22 , pp. 325-331
    • Kaji, H.1    Suzuki, M.2    Yano, S.3
  • 170
    • 0036202657 scopus 로고    scopus 로고
    • Bone mineral density in patients beginning hemodialysis treatment
    • Pecovnik Balon B, Hojs R, Zavratnik A et al. Bone mineral density in patients beginning hemodialysis treatment. Am J Nephrol 2002; 22: 14-17.
    • (2002) Am J Nephrol , vol.22 , pp. 14-17
    • Pecovnik Balon, B.1    Hojs, R.2    Zavratnik, A.3
  • 171
    • 10744233214 scopus 로고    scopus 로고
    • Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients
    • Ghazali A, Grados F, Oprisiu R et al. Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 1882-1890.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 1882-1890
    • Ghazali, A.1    Grados, F.2    Oprisiu, R.3
  • 172
    • 0037316835 scopus 로고    scopus 로고
    • Influence of body composition on 5 year mortality in patients on regular haemodialysis
    • Kato A, Odamaki M, Yamamoto T et al. Influence of body composition on 5 year mortality in patients on regular haemodialysis. Nephrol Dial Transplant 2003; 18: 333-340.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 333-340
    • Kato, A.1    Odamaki, M.2    Yamamoto, T.3
  • 173
    • 0346754948 scopus 로고    scopus 로고
    • Bone mineral density changes within six months of renal transplantation
    • Mikuls TR, Julian BA, Bartolucci A et al. Bone mineral density changes within six months of renal transplantation. Transplantation 2003; 75: 49-54.
    • (2003) Transplantation , vol.75 , pp. 49-54
    • Mikuls, T.R.1    Julian, B.A.2    Bartolucci, A.3
  • 174
    • 0041705939 scopus 로고    scopus 로고
    • Bone mineral density may be related to atherosclerosis in hemodialysis patients
    • Nakashima A, Yorioka N, Tanji C et al. Bone mineral density may be related to atherosclerosis in hemodialysis patients. Osteoporos Int 2003; 14: 369-373.
    • (2003) Osteoporos Int , vol.14 , pp. 369-373
    • Nakashima, A.1    Yorioka, N.2    Tanji, C.3
  • 175
    • 0242270888 scopus 로고    scopus 로고
    • Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients
    • Urena P, Bernard-Poenaru O, Ostertag A et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 2325-2331.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 2325-2331
    • Urena, P.1    Bernard-Poenaru, O.2    Ostertag, A.3
  • 176
    • 3142606742 scopus 로고    scopus 로고
    • Predictors of bone mineral density in patients on hemodialysis
    • Zayour D, Daouk M, Medawar W et al. Predictors of bone mineral density in patients on hemodialysis. Transplant Proc 2004; 36: 1297-1301.
    • (2004) Transplant Proc , vol.36 , pp. 1297-1301
    • Zayour, D.1    Daouk, M.2    Medawar, W.3
  • 177
    • 24044523176 scopus 로고    scopus 로고
    • Osteoprotegerin and bone mineral density in hemodiafiltration patients
    • Crisafulli A, Romeo A, Floccari F et al. Osteoprotegerin and bone mineral density in hemodiafiltration patients. Ren Fail 2005; 27: 531-539.
    • (2005) Ren Fail , vol.27 , pp. 531-539
    • Crisafulli, A.1    Romeo, A.2    Floccari, F.3
  • 178
    • 28044438380 scopus 로고    scopus 로고
    • Serum concentrations of cross-linked N-telopeptides of type I collagen: New marker for bone resorption in hemodialysis patients
    • Maeno Y, Inaba M, Okuno S et al. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients. Clin Chem 2005; 51: 2312-2317.
    • (2005) Clin Chem , vol.51 , pp. 2312-2317
    • Maeno, Y.1    Inaba, M.2    Okuno, S.3
  • 179
    • 28444440170 scopus 로고    scopus 로고
    • Effects of short-term alendronate on bone mineral density in haemodialysis patients
    • Wetmore JB, Benet LZ, Kleinstuck D et al. Effects of short-term alendronate on bone mineral density in haemodialysis patients. Nephrology (Carlton) 2005; 10: 393-399.
    • (2005) Nephrology (Carlton) , vol.10 , pp. 393-399
    • Wetmore, J.B.1    Benet, L.Z.2    Kleinstuck, D.3
  • 180
    • 33846465088 scopus 로고    scopus 로고
    • 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease
    • Elder GJ, Mackun K. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res 2006; 21: 1778-1784.
    • (2006) J Bone Miner Res , vol.21 , pp. 1778-1784
    • Elder, G.J.1    Mackun, K.2
  • 181
    • 29244454547 scopus 로고    scopus 로고
    • Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients
    • Ersoy FF, Passadakis SP, Tam P et al. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab 2006; 24: 79-86.
    • (2006) J Bone Miner Metab , vol.24 , pp. 79-86
    • Ersoy, F.F.1    Passadakis, S.P.2    Tam, P.3
  • 182
    • 33646886129 scopus 로고    scopus 로고
    • Osteoprotegerin and bone mineral density in hemodialysis patients
    • Nakashima A, Yorioka N, Doi S et al. Osteoprotegerin and bone mineral density in hemodialysis patients. Osteoporos Int 2006; 17: 841-846.
    • (2006) Osteoporos Int , vol.17 , pp. 841-846
    • Nakashima, A.1    Yorioka, N.2    Doi, S.3
  • 183
    • 0343570527 scopus 로고    scopus 로고
    • An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation
    • Kanis JA, Gluer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 2000; 11: 192-202.
    • (2000) Osteoporos Int , vol.11 , pp. 192-202
    • Kanis, J.A.1    Gluer, C.C.2
  • 184
    • 20844462737 scopus 로고    scopus 로고
    • Predictive value of BMD for hip and other fractures
    • Johnell O, Kanis JA, Oden A et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005; 20: 1185-1194.
    • (2005) J Bone Miner Res , vol.20 , pp. 1185-1194
    • Johnell, O.1    Kanis, J.A.2    Oden, A.3
  • 185
    • 43049175471 scopus 로고    scopus 로고
    • FRAX and the assessment of fracture probability in men and women from the UK
    • Kanis JA, Johnell O, Oden A et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385-397.
    • (2008) Osteoporos Int , vol.19 , pp. 385-397
    • Kanis, J.A.1    Johnell, O.2    Oden, A.3
  • 186
    • 34347372696 scopus 로고    scopus 로고
    • The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
    • Kanis JA, Oden A, Johnell O et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007; 18: 1033-1046.
    • (2007) Osteoporos Int , vol.18 , pp. 1033-1046
    • Kanis, J.A.1    Oden, A.2    Johnell, O.3
  • 187
    • 33748071110 scopus 로고    scopus 로고
    • Association between bone mass and fractures in children: A prospective cohort study
    • Clark EM, Ness AR, Bishop NJ et al. Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 2006; 21: 1489-1495.
    • (2006) J Bone Miner Res , vol.21 , pp. 1489-1495
    • Clark, E.M.1    Ness, A.R.2    Bishop, N.J.3
  • 188
    • 0036196468 scopus 로고    scopus 로고
    • Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures
    • Jamal SA, Chase C, Goh YI et al. Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 2002; 39: 843-849.
    • (2002) Am J Kidney Dis , vol.39 , pp. 843-849
    • Jamal, S.A.1    Chase, C.2    Goh, Y.I.3
  • 189
    • 1942486711 scopus 로고    scopus 로고
    • Bone mineral density: Serum markers of bone turnover and their relationships in peritoneal dialysis
    • Negri AL, Barone R, Quiroga MA et al. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis. Perit Dial Int 2004; 24: 163-168.
    • (2004) Perit Dial Int , vol.24 , pp. 163-168
    • Negri, A.L.1    Barone, R.2    Quiroga, M.A.3
  • 190
    • 0033811890 scopus 로고    scopus 로고
    • Fracture and bone mineral density in hemodialysis patients
    • Fontaine MA, Albert A, Dubois B et al. Fracture and bone mineral density in hemodialysis patients. Clin Nephrol 2000; 54: 218-226.
    • (2000) Clin Nephrol , vol.54 , pp. 218-226
    • Fontaine, M.A.1    Albert, A.2    Dubois, B.3
  • 191
    • 22244463889 scopus 로고    scopus 로고
    • Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus
    • Inaba M, Okuno S, Kumeda Y et al. Increased incidence of vertebral
    • (2005) Calcif Tissue Int , vol.76 , pp. 256-260
    • Inaba, M.1    Okuno, S.2    Kumeda, Y.3
  • 192
    • 33645334942 scopus 로고    scopus 로고
    • Cortical pQCT measures are associated with fractures in dialysis patients
    • Jamal SA, Gilbert J, Gordon C et al. Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 2006; 21: 543-548.
    • (2006) J Bone Miner Res , vol.21 , pp. 543-548
    • Jamal, S.A.1    Gilbert, J.2    Gordon, C.3
  • 193
    • 29044447566 scopus 로고    scopus 로고
    • In elderly men and women treated for osteoporosis a low creatinine clearance of o 65 ml/min is a risk factor for falls and fractures
    • Dukas L, Schacht E, Stahelin HB. In elderly men and women treated for osteoporosis a low creatinine clearance of o 65 ml/min is a risk factor for falls and fractures. Osteoporos Int 2005; 16: 1683-1690.
    • (2005) Osteoporos Int , vol.16 , pp. 1683-1690
    • Dukas, L.1    Schacht, E.2    Stahelin, H.B.3
  • 194
    • 42949107661 scopus 로고    scopus 로고
    • Geriatric comorbidities, such as falls, confer an independent mortality risk to elderly dialysis patients
    • Li M, Tomlinson G, Naglie G et al. Geriatric comorbidities, such as falls, confer an independent mortality risk to elderly dialysis patients. Nephrol Dial Transplant 2008; 23: 1396-1400.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 1396-1400
    • Li, M.1    Tomlinson, G.2    Naglie, G.3
  • 195
    • 34250738124 scopus 로고    scopus 로고
    • Falls and fall-related injuries in older dialysis patients
    • Cook WL, Tomlinson G, Donaldson M et al. Falls and fall-related injuries in older dialysis patients. Clin J Am Soc Nephrol 2006; 1: 1197-1204.
    • (2006) Clin J Am Soc Nephrol , vol.1 , pp. 1197-1204
    • Cook, W.L.1    Tomlinson, G.2    Donaldson, M.3
  • 196
    • 11144263554 scopus 로고    scopus 로고
    • Falls in hemodialysis patients: Prospective study of incidence, risk factors, and complications
    • Desmet C, Beguin C, Swine C et al. Falls in hemodialysis patients: prospective study of incidence, risk factors, and complications. Am J Kidney Dis 2005; 45: 148-153.
    • (2005) Am J Kidney Dis , vol.45 , pp. 148-153
    • Desmet, C.1    Beguin, C.2    Swine, C.3
  • 197
    • 0023038385 scopus 로고
    • Comparison of histomorphometry and computerized tomography of the spine in quantitating trabecular bone in renal osteodystrophy
    • Torres A, Lorenzo V, Gonzalez-Posada JM. Comparison of histomorphometry and computerized tomography of the spine in quantitating trabecular bone in renal osteodystrophy. Nephron 1986; 44: 282-287.
    • (1986) Nephron , vol.44 , pp. 282-287
    • Torres, A.1    Lorenzo, V.2    Gonzalez-Posada, J.M.3
  • 198
    • 34248180551 scopus 로고    scopus 로고
    • Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis
    • Van Eps CL, Jeffries JK, Anderson JA et al. Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology (Carlton) 2007; 12: 224-233.
    • (2007) Nephrology (Carlton) , vol.12 , pp. 224-233
    • Van Eps, C.L.1    Jeffries, J.K.2    Anderson, J.A.3
  • 199
    • 0026670524 scopus 로고
    • Assessment of renal osteodystrophy in hemodialysis patients
    • DeVita MV, Rasenas LL, Bansal M et al. Assessment of renal osteodystrophy in hemodialysis patients. Medicine (Baltimore) 1992; 71: 284-290.
    • (1992) Medicine (Baltimore) , vol.71 , pp. 284-290
    • DeVita, M.V.1    Rasenas, L.L.2    Bansal, M.3
  • 200
    • 0031801035 scopus 로고    scopus 로고
    • Mineralized bone loss at different sites in dialysis patients: Implications for prevention
    • Schober HC, Han ZH, Foldes AJ et al. Mineralized bone loss at different sites in dialysis patients: implications for prevention. J Am Soc Nephrol 1998; 9: 1225-1233.
    • (1998) J Am Soc Nephrol , vol.9 , pp. 1225-1233
    • Schober, H.C.1    Han, Z.H.2    Foldes, A.J.3
  • 201
    • 0027190369 scopus 로고
    • Non-invasive measurements of bone mass in adult renal osteodystrophy
    • Boling E, Primavera C, Friedman G et al. Non-invasive measurements of bone mass in adult renal osteodystrophy. Bone 1993; 14: 409-413.
    • (1993) Bone , vol.14 , pp. 409-413
    • Boling, E.1    Primavera, C.2    Friedman, G.3
  • 202
    • 0030903678 scopus 로고    scopus 로고
    • Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology
    • Fletcher S, Jones RG, Rayner HC et al. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron 1997; 75: 412-419.
    • (1997) Nephron , vol.75 , pp. 412-419
    • Fletcher, S.1    Jones, R.G.2    Rayner, H.C.3
  • 203
    • 12244254430 scopus 로고    scopus 로고
    • Total hip bone mass predicts survival in chronic hemodialysis patients
    • Taal MW, Roe S, Masud T et al. Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 2003; 63: 1116-1120.
    • (2003) Kidney Int , vol.63 , pp. 1116-1120
    • Taal, M.W.1    Roe, S.2    Masud, T.3
  • 204
    • 0038129843 scopus 로고    scopus 로고
    • Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis
    • Stehman-Breen C, Anderson G, Gibson D et al. Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis. Kidney Int 2003; 64: 290-294.
    • (2003) Kidney Int , vol.64 , pp. 290-294
    • Stehman-Breen, C.1    Anderson, G.2    Gibson, D.3
  • 205
    • 3543139492 scopus 로고    scopus 로고
    • Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
    • Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2208-2218
    • Block, G.A.1    Klassen, P.S.2    Lazarus, J.M.3
  • 206
    • 33748938551 scopus 로고    scopus 로고
    • Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study
    • Jadoul M, Albert JM, Akiba T et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2006; 70: 1358-1366.
    • (2006) Kidney Int , vol.70 , pp. 1358-1366
    • Jadoul, M.1    Albert, J.M.2    Akiba, T.3
  • 207
    • 33846095863 scopus 로고    scopus 로고
    • Age and sex are sufficient for predicting fractures occurring within 1 year of hemodialysis treatment
    • Mitterbauer C, Kramar R, Oberbauer R. Age and sex are sufficient for predicting fractures occurring within 1 year of hemodialysis treatment. Bone 2007; 40: 516-521.
    • (2007) Bone , vol.40 , pp. 516-521
    • Mitterbauer, C.1    Kramar, R.2    Oberbauer, R.3
  • 208
    • 34248164557 scopus 로고    scopus 로고
    • Osteoporosis in the elderly with chronic kidney disease
    • Ersoy FF. Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol 2007; 39: 321-331.
    • (2007) Int Urol Nephrol , vol.39 , pp. 321-331
    • Ersoy, F.F.1
  • 209
    • 34547639131 scopus 로고    scopus 로고
    • Fracture risk after parathyroidectomy among chronic hemodialysis patients
    • Rudser KD, de Boer IH, Dooley A et al. Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 2007; 18: 2401-2407.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2401-2407
    • Rudser, K.D.1    de Boer, I.H.2    Dooley, A.3
  • 210
    • 0019785250 scopus 로고
    • Bone histomorphometric reproducibility in normal patients
    • de Vernejoul MC, Kuntz D, Miravet L et al. Bone histomorphometric reproducibility in normal patients. Calcif Tissue Int 1981; 33: 369-374.
    • (1981) Calcif Tissue Int , vol.33 , pp. 369-374
    • de Vernejoul, M.C.1    Kuntz, D.2    Miravet, L.3
  • 211
    • 0022969183 scopus 로고
    • Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy
    • Andress DL, Endres DB, Maloney NA et al. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab 1986; 63: 1163-1169.
    • (1986) J Clin Endocrinol Metab , vol.63 , pp. 1163-1169
    • Andress, D.L.1    Endres, D.B.2    Maloney, N.A.3
  • 212
    • 0024412717 scopus 로고
    • Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure
    • Andress DL, Norris KC, Coburn JW et al. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 1989; 321: 274-279.
    • (1989) N Engl J Med , vol.321 , pp. 274-279
    • Andress, D.L.1    Norris, K.C.2    Coburn, J.W.3
  • 213
    • 0026652885 scopus 로고
    • Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia
    • Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992; 75: 145-150.
    • (1992) J Clin Endocrinol Metab , vol.75 , pp. 145-150
    • Quarles, L.D.1    Lobaugh, B.2    Murphy, G.3
  • 214
    • 0027178439 scopus 로고
    • The spectrum of bone disease in end-stage renal failure - an evolving disorder
    • Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 1993; 43: 436-442.
    • (1993) Kidney Int , vol.43 , pp. 436-442
    • Sherrard, D.J.1    Hercz, G.2    Pei, Y.3
  • 215
    • 0029036314 scopus 로고
    • Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH
    • Torres A, Lorenzo V, Hernandez D et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 1995; 47: 1434-1442.
    • (1995) Kidney Int , vol.47 , pp. 1434-1442
    • Torres, A.1    Lorenzo, V.2    Hernandez, D.3
  • 216
    • 0028788558 scopus 로고
    • Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
    • Wang M, Hercz G, Sherrard DJ et al. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 1995; 26: 836-844.
    • (1995) Am J Kidney Dis , vol.26 , pp. 836-844
    • Wang, M.1    Hercz, G.2    Sherrard, D.J.3
  • 217
    • 0028873776 scopus 로고
    • Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy
    • Mazzaferro S, Pasquali M, Ballanti P et al. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy. Nephrol Dial Transplant 1995; 10: 52-58.
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 52-58
    • Mazzaferro, S.1    Pasquali, M.2    Ballanti, P.3
  • 218
    • 0030469027 scopus 로고    scopus 로고
    • Biochemical markers for noninvasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis
    • Gerakis A, Hutchison AJ, Apostolou T et al. Biochemical markers for noninvasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. Nephrol Dial Transplant 1996; 11: 2430-2438.
    • (1996) Nephrol Dial Transplant , vol.11 , pp. 2430-2438
    • Gerakis, A.1    Hutchison, A.J.2    Apostolou, T.3
  • 219
    • 0029921693 scopus 로고    scopus 로고
    • Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients
    • Urena P, Hruby M, Ferreira A et al. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 1996; 7: 506-512.
    • (1996) J Am Soc Nephrol , vol.7 , pp. 506-512
    • Urena, P.1    Hruby, M.2    Ferreira, A.3
  • 220
    • 0010516414 scopus 로고    scopus 로고
    • Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients
    • Coen G, Ballanti P, Bonucci E et al. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 2294-2302.
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 2294-2302
    • Coen, G.1    Ballanti, P.2    Bonucci, E.3
  • 221
    • 0033753097 scopus 로고    scopus 로고
    • Parathormone secretion in peritoneal dialysis patients with adynamic bone disease
    • Carmen Sanchez M, Auxiliadora Bajo M, Selgas R et al. Parathormone secretion in peritoneal dialysis patients with adynamic bone disease. Am J Kidney Dis 2000; 36: 953-961.
    • (2000) Am J Kidney Dis , vol.36 , pp. 953-961
    • Carmen Sanchez, M.1    Auxiliadora Bajo, M.2    Selgas, R.3
  • 222
    • 0038417873 scopus 로고    scopus 로고
    • Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients
    • Bervoets AR, Spasovski GB, Behets GJ et al. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Am J Kidney Dis 2003; 41: 997-1007.
    • (2003) Am J Kidney Dis , vol.41 , pp. 997-1007
    • Bervoets, A.R.1    Spasovski, G.B.2    Behets, G.J.3
  • 223
    • 17444366563 scopus 로고    scopus 로고
    • New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels
    • Gal-Moscovici A, Popovtzer MM. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Clin Nephrol 2005; 63: 284-289.
    • (2005) Clin Nephrol , vol.63 , pp. 284-289
    • Gal-Moscovici, A.1    Popovtzer, M.M.2
  • 224
    • 33745211250 scopus 로고    scopus 로고
    • Renal osteodystrophy: Alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry
    • Coen G, Ballanti P, Balducci A et al. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry. Am J Kidney Dis 2006; 48: 106-113.
    • (2006) Am J Kidney Dis , vol.48 , pp. 106-113
    • Coen, G.1    Ballanti, P.2    Balducci, A.3
  • 225
    • 0024548747 scopus 로고
    • Serum bioactive parathyroid hormone in hemodialysis patients
    • McCarthy JT, Klee GG, Kao PC et al. Serum bioactive parathyroid hormone in hemodialysis patients. J Clin Endocrinol Metab 1989; 68: 340-345.
    • (1989) J Clin Endocrinol Metab , vol.68 , pp. 340-345
    • McCarthy, J.T.1    Klee, G.G.2    Kao, P.C.3
  • 226
    • 0029118191 scopus 로고
    • Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis
    • Qi Q, Monier-Faugere MC, Geng Z et al. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995; 26: 622-631.
    • (1995) Am J Kidney Dis , vol.26 , pp. 622-631
    • Qi, Q.1    Monier-Faugere, M.C.2    Geng, Z.3
  • 227
    • 0029900410 scopus 로고    scopus 로고
    • Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in haemodialysis patients
    • Couttenye MM, D'Haese PC, Van Hoof VO et al. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 1996; 11: 1065-1072.
    • (1996) Nephrol Dial Transplant , vol.11 , pp. 1065-1072
    • Couttenye, M.M.1    D'Haese, P.C.2    Van Hoof, V.O.3
  • 228
    • 54949142792 scopus 로고    scopus 로고
    • Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3-5
    • Lehmann G, Ott U, Kaemmerer D et al. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3-5. Clin Nephrol 2008; 70: 296-305.
    • (2008) Clin Nephrol , vol.70 , pp. 296-305
    • Lehmann, G.1    Ott, U.2    Kaemmerer, D.3
  • 229
    • 40049097821 scopus 로고    scopus 로고
    • K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients
    • Barreto FC, Barreto DV, Moyses RM et al. K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 2008; 73: 771-777.
    • (2008) Kidney Int , vol.73 , pp. 771-777
    • Barreto, F.C.1    Barreto, D.V.2    Moyses, R.M.3
  • 230
    • 0027496973 scopus 로고
    • Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease
    • Hutchison AJ, Whitehouse RW, Boulton HF et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071-1077.
    • (1993) Kidney Int , vol.44 , pp. 1071-1077
    • Hutchison, A.J.1    Whitehouse, R.W.2    Boulton, H.F.3
  • 231
    • 33646672891 scopus 로고    scopus 로고
    • Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
    • Barreto FC, Barreto DV, Moyses RM et al. Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int 2006; 69: 1852-1857.
    • (2006) Kidney Int , vol.69 , pp. 1852-1857
    • Barreto, F.C.1    Barreto, D.V.2    Moyses, R.M.3
  • 232
    • 0033935833 scopus 로고    scopus 로고
    • Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
    • Jehle PM, Ostertag A, Schulten K et al. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int 2000; 57: 423-436.
    • (2000) Kidney Int , vol.57 , pp. 423-436
    • Jehle, P.M.1    Ostertag, A.2    Schulten, K.3
  • 233
    • 0032828179 scopus 로고    scopus 로고
    • Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
    • Rix M, Andreassen H, Eskildsen P et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 1999; 56: 1084-1093.
    • (1999) Kidney Int , vol.56 , pp. 1084-1093
    • Rix, M.1    Andreassen, H.2    Eskildsen, P.3
  • 234
    • 13244265633 scopus 로고    scopus 로고
    • The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure
    • Tsuchida T, Ishimura E, Miki T et al. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure. Osteoporos Int 2005; 16: 172-179.
    • (2005) Osteoporos Int , vol.16 , pp. 172-179
    • Tsuchida, T.1    Ishimura, E.2    Miki, T.3
  • 235
    • 33845777568 scopus 로고    scopus 로고
    • Annual change in bone mineral density in predialysis patients with chronic renal failure: Significance of a decrease in serum 1,25-dihydroxy-vitamin D
    • Obatake N, Ishimura E, Tsuchida T et al. Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D. J Bone Miner Metab 2007; 25: 74-79.
    • (2007) J Bone Miner Metab , vol.25 , pp. 74-79
    • Obatake, N.1    Ishimura, E.2    Tsuchida, T.3
  • 236
    • 0036788313 scopus 로고    scopus 로고
    • Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients
    • Ueda M, Inaba M, Okuno S et al. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 2002; 40: 802-809.
    • (2002) Am J Kidney Dis , vol.40 , pp. 802-809
    • Ueda, M.1    Inaba, M.2    Okuno, S.3
  • 237
    • 33745455378 scopus 로고    scopus 로고
    • OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis
    • Wittersheim E, Mesquita M, Demulder A et al. OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis. Clin Biochem 2006; 39: 617-622.
    • (2006) Clin Biochem , vol.39 , pp. 617-622
    • Wittersheim, E.1    Mesquita, M.2    Demulder, A.3
  • 238
    • 37249051311 scopus 로고    scopus 로고
    • Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients
    • Sit D, Kadiroglu AK, Kayabasi H et al. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients. Adv Ther 2007; 24: 987-995.
    • (2007) Adv Ther , vol.24 , pp. 987-995
    • Sit, D.1    Kadiroglu, A.K.2    Kayabasi, H.3
  • 239
    • 37349026168 scopus 로고    scopus 로고
    • Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients
    • Doumouchtsis KK, Kostakis AI, Doumouchtsis SK et al. Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. J Bone Miner Metab 2008; 26: 66-72.
    • (2008) J Bone Miner Metab , vol.26 , pp. 66-72
    • Doumouchtsis, K.K.1    Kostakis, A.I.2    Doumouchtsis, S.K.3
  • 240
    • 0033021783 scopus 로고    scopus 로고
    • Circulating biochemical markers of bone remodeling in uremic patients
    • Urena P, De Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 1999; 55: 2141-2156.
    • (1999) Kidney Int , vol.55 , pp. 2141-2156
    • Urena, P.1    De Vernejoul, M.C.2
  • 241
    • 34548078704 scopus 로고    scopus 로고
    • Effect of fracture on bone turnover markers: A longitudinal study comparing marker levels before and after injury in 113 elderly women
    • Ivaska KK, Gerdhem P, Akesson K et al. Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Miner Res 2007; 22: 1155-1164.
    • (2007) J Bone Miner Res , vol.22 , pp. 1155-1164
    • Ivaska, K.K.1    Gerdhem, P.2    Akesson, K.3
  • 242
    • 27744599521 scopus 로고    scopus 로고
    • Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: Clinical utility in metabolic bone disease assessment
    • Rogers A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005; 90: 6323-6331.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 6323-6331
    • Rogers, A.1    Eastell, R.2
  • 243
    • 49249104701 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
    • Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. NEngl J Med 2008; 359: 584-592.
    • (2008) NEngl J Med , vol.359 , pp. 584-592
    • Gutierrez, O.M.1    Mannstadt, M.2    Isakova, T.3
  • 244
    • 0343517092 scopus 로고    scopus 로고
    • Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study
    • Garnero P, Sornay-Rendu E, Claustrat B et al. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000; 15: 1526-1536.
    • (2000) J Bone Miner Res , vol.15 , pp. 1526-1536
    • Garnero, P.1    Sornay-Rendu, E.2    Claustrat, B.3
  • 245
    • 0036068423 scopus 로고    scopus 로고
    • Biochemical indices of bone turnover and the assessment of fracture probability
    • Johnell O, Oden A, De Laet C et al. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 2002; 13: 523-526.
    • (2002) Osteoporos Int , vol.13 , pp. 523-526
    • Johnell, O.1    Oden, A.2    De Laet, C.3
  • 246
    • 2942730031 scopus 로고    scopus 로고
    • Biochemical markers of bone metabolism and prediction of fracture in elderly women
    • Gerdhem P, Ivaska KK, Alatalo SL et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004; 19: 386-393.
    • (2004) J Bone Miner Res , vol.19 , pp. 386-393
    • Gerdhem, P.1    Ivaska, K.K.2    Alatalo, S.L.3
  • 247
    • 13144306555 scopus 로고    scopus 로고
    • Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: The fracture intervention trial
    • Bauer DC, Black DM, Garnero P et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res 2004; 19: 1250-1258.
    • (2004) J Bone Miner Res , vol.19 , pp. 1250-1258
    • Bauer, D.C.1    Black, D.M.2    Garnero, P.3
  • 248
    • 33144489593 scopus 로고    scopus 로고
    • Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: The fracture intervention trial
    • Bauer DC, Garnero P, Hochberg MC et al. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res 2006; 21: 292-299.
    • (2006) J Bone Miner Res , vol.21 , pp. 292-299
    • Bauer, D.C.1    Garnero, P.2    Hochberg, M.C.3
  • 249
    • 2942739433 scopus 로고    scopus 로고
    • Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk
    • Sarkar S, Reginster JY, Crans GG et al. Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J Bone Miner Res 2004; 19: 394-401.
    • (2004) J Bone Miner Res , vol.19 , pp. 394-401
    • Sarkar, S.1    Reginster, J.Y.2    Crans, G.G.3
  • 250
    • 54249123586 scopus 로고    scopus 로고
    • Bone markers predict cardiovascular events in chronic kidney disease
    • Fahrleitner-Pammer A, Herberth J, Browning SR et al. Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res 2008; 23: 1850-1858.
    • (2008) J Bone Miner Res , vol.23 , pp. 1850-1858
    • Fahrleitner-Pammer, A.1    Herberth, J.2    Browning, S.R.3
  • 251
    • 0033839670 scopus 로고    scopus 로고
    • Clinical use of biochemical markers of bone remodeling: Current status and future directions
    • Looker AC, Bauer DC, Chesnut III CH et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 2000; 11: 467-480.
    • (2000) Osteoporos Int , vol.11 , pp. 467-480
    • Looker, A.C.1    Bauer, D.C.2    Chesnut III, C.H.3
  • 252
    • 84863791142 scopus 로고    scopus 로고
    • NAPRTCS: Boston
    • North American Pediatric Renal Trials and Collaborative Studies:, MA
    • Talley L, Stablein DM. North American Pediatric Renal Trials and Collaborative Studies: NAPRTCS 2006 Annual Report. NAPRTCS: Boston, MA, 2006, pp 1-270.
    • (2006) NAPRTCS 2006 Annual Report , pp. 1-270
    • Talley, L.1    Stablein, D.M.2
  • 253
    • 0036161247 scopus 로고    scopus 로고
    • Stroke is associated with coronary calcification as detected by electron-beam CT: The Rotterdam Coronary Calcification Study
    • Vliegenthart R, Hollander M, Breteler MM et al. Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study. Stroke 2002; 33: 462-465.
    • (2002) Stroke , vol.33 , pp. 462-465
    • Vliegenthart, R.1    Hollander, M.2    Breteler, M.M.3
  • 254
    • 0036800034 scopus 로고    scopus 로고
    • Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study
    • Vliegenthart R, Oudkerk M, Song B et al. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J 2002; 23: 1596-1603.
    • (2002) Eur Heart J , vol.23 , pp. 1596-1603
    • Vliegenthart, R.1    Oudkerk, M.2    Song, B.3
  • 255
    • 3142665471 scopus 로고    scopus 로고
    • The association of Rose questionnaire angina pectoris and coronary calcification in a general population: The Rotterdam Coronary Calcification Study
    • Oei HH, Vliegenthart R, Deckers JW et al. The association of Rose questionnaire angina pectoris and coronary calcification in a general population: the Rotterdam Coronary Calcification Study. Ann Epidemiol 2004; 14: 431-436.
    • (2004) Ann Epidemiol , vol.14 , pp. 431-436
    • Oei, H.H.1    Vliegenthart, R.2    Deckers, J.W.3
  • 256
    • 58149352649 scopus 로고    scopus 로고
    • Accelerated atherosclerotic calcification and Monckeberg's sclerosis: A continuum of advanced vascular pathology in chronic kidney disease
    • McCullough PA, Agrawal V, Danielewicz E et al. Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1585-1598.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1585-1598
    • McCullough, P.A.1    Agrawal, V.2    Danielewicz, E.3
  • 257
    • 58149339930 scopus 로고    scopus 로고
    • Media calcification and intima calcification are distinct entities in chronic kidney disease
    • Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1599-1605.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1599-1605
    • Amann, K.1
  • 258
    • 0033967686 scopus 로고    scopus 로고
    • Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
    • Schwarz U, Buzello M, Ritz E et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-223.
    • (2000) Nephrol Dial Transplant , vol.15 , pp. 218-223
    • Schwarz, U.1    Buzello, M.2    Ritz, E.3
  • 259
    • 34548529829 scopus 로고    scopus 로고
    • Calcification of coronary intima and media: Immunohisto chemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients
    • Gross ML, Meyer HP, Ziebart H et al. Calcification of coronary intima and media: immunohisto chemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2007; 2: 121-134.
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 121-134
    • Gross, M.L.1    Meyer, H.P.2    Ziebart, H.3
  • 260
    • 0037337818 scopus 로고    scopus 로고
    • Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels
    • Moe SM, Duan D, Doehle BP et al. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003; 63: 1003-1011.
    • (2003) Kidney Int , vol.63 , pp. 1003-1011
    • Moe, S.M.1    Duan, D.2    Doehle, B.P.3
  • 261
    • 0018748311 scopus 로고
    • Arterial calcification and pathology in uremic patients undergoing dialysis
    • Ibels LS, Alfrey AC, Huffer WE et al. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 1979; 66: 790-796.
    • (1979) Am J Med , vol.66 , pp. 790-796
    • Ibels, L.S.1    Alfrey, A.C.2    Huffer, W.E.3
  • 262
    • 9644276844 scopus 로고    scopus 로고
    • Vascular calcification mechanisms
    • Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2959-2964
    • Giachelli, C.M.1
  • 263
    • 0036707883 scopus 로고    scopus 로고
    • The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats
    • Cozzolino M, Dusso AS, Liapis H et al. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. J Am Soc Nephrol 2002; 13: 2299-2308.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 2299-2308
    • Cozzolino, M.1    Dusso, A.S.2    Liapis, H.3
  • 264
    • 33845982605 scopus 로고    scopus 로고
    • Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy
    • Mathew S, Lund RJ, Strebeck F et al. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol 2007; 18: 122-130.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 122-130
    • Mathew, S.1    Lund, R.J.2    Strebeck, F.3
  • 265
    • 33847223412 scopus 로고    scopus 로고
    • Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
    • Block GA, Raggi P, Bellasi A et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441.
    • (2007) Kidney Int , vol.71 , pp. 438-441
    • Block, G.A.1    Raggi, P.2    Bellasi, A.3
  • 266
    • 35349004713 scopus 로고    scopus 로고
    • Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
    • Suki WN, Zabaneh R, Cangiano JL et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 2007; 72: 1130-1137.
    • (2007) Kidney Int , vol.72 , pp. 1130-1137
    • Suki, W.N.1    Zabaneh, R.2    Cangiano, J.L.3
  • 267
    • 39449117385 scopus 로고    scopus 로고
    • A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: A secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data
    • St Peter WL, Liu J, Weinhandl E et al. A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data. Am J Kidney Dis 2008; 51: 445-454.
    • (2008) Am J Kidney Dis , vol.51 , pp. 445-454
    • St Peter, W.L.1    Liu, J.2    Weinhandl, E.3
  • 268
    • 0015905208 scopus 로고
    • Evolution of bone disease over 10 years in 135 patients with terminal renal failure
    • Tatler GL, Baillod RA, Varghese Z et al. Evolution of bone disease over 10 years in 135 patients with terminal renal failure. BMJ 1973; 4: 315-319.
    • (1973) BMJ , vol.4 , pp. 315-319
    • Tatler, G.L.1    Baillod, R.A.2    Varghese, Z.3
  • 269
    • 0016201538 scopus 로고
    • Deaths from occlusive arterial disease in renal allograft recipients
    • Ibels LS, Stewart JH, Mahony JF et al. Deaths from occlusive arterial disease in renal allograft recipients. BMJ 1974; 3: 552-554.
    • (1974) BMJ , vol.3 , pp. 552-554
    • Ibels, L.S.1    Stewart, J.H.2    Mahony, J.F.3
  • 270
    • 33745003930 scopus 로고    scopus 로고
    • Calcification and cardiovascular health: New insights into an old phenomenon
    • Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 2006; 47: 1027-1034.
    • (2006) Hypertension , vol.47 , pp. 1027-1034
    • Ketteler, M.1    Schlieper, G.2    Floege, J.3
  • 271
    • 18244392685 scopus 로고    scopus 로고
    • Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone
    • Murshed M, Harmey D, Millan JL et al. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 2005; 19: 1093-1104.
    • (2005) Genes Dev , vol.19 , pp. 1093-1104
    • Murshed, M.1    Harmey, D.2    Millan, J.L.3
  • 272
    • 33750213879 scopus 로고    scopus 로고
    • Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients
    • Bellasi A, Ferramosca E, Muntner P et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int 2006; 70: 1623-1628.
    • (2006) Kidney Int , vol.70 , pp. 1623-1628
    • Bellasi, A.1    Ferramosca, E.2    Muntner, P.3
  • 273
    • 2342449951 scopus 로고    scopus 로고
    • Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients
    • Haydar AA, Covic A, Colhoun H et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004; 65: 1790-1794.
    • (2004) Kidney Int , vol.65 , pp. 1790-1794
    • Haydar, A.A.1    Covic, A.2    Colhoun, H.3
  • 274
    • 5044233408 scopus 로고    scopus 로고
    • Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan
    • Nitta K, Akiba T, Suzuki K et al. Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens Res 2004; 27: 527-533.
    • (2004) Hypertens Res , vol.27 , pp. 527-533
    • Nitta, K.1    Akiba, T.2    Suzuki, K.3
  • 275
    • 33644849893 scopus 로고    scopus 로고
    • Vascular calcification and cardiovascular function in chronic kidney disease
    • Sigrist M, Bungay P, Taal MW et al. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 707-714
    • Sigrist, M.1    Bungay, P.2    Taal, M.W.3
  • 276
    • 33749262975 scopus 로고    scopus 로고
    • Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis
    • Stompor T, Rajzer M, Pasowicz M et al. Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis. Int J Artif Organs 2006; 29: 736-744.
    • (2006) Int J Artif Organs , vol.29 , pp. 736-744
    • Stompor, T.1    Rajzer, M.2    Pasowicz, M.3
  • 277
    • 34247204360 scopus 로고    scopus 로고
    • Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients
    • Raggi P, Bellasi A, Ferramosca E et al. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 2007; 71: 802-807.
    • (2007) Kidney Int , vol.71 , pp. 802-807
    • Raggi, P.1    Bellasi, A.2    Ferramosca, E.3
  • 278
    • 35848930378 scopus 로고    scopus 로고
    • Mineral metabolism and vascular damage in children on dialysis
    • Shroff RC, Donald AE, Hiorns MP et al. Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 2007; 18: 2996-3003.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2996-3003
    • Shroff, R.C.1    Donald, A.E.2    Hiorns, M.P.3
  • 279
    • 0034682247 scopus 로고    scopus 로고
    • Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
    • Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
    • (2000) N Engl J Med , vol.342 , pp. 1478-1483
    • Goodman, W.G.1    Goldin, J.2    Kuizon, B.D.3
  • 280
    • 0036486821 scopus 로고    scopus 로고
    • Coronary artery calcification and dietary cholesterol intake in Korean men
    • Oh KW, Nam CM, Jee SH et al. Coronary artery calcification and dietary cholesterol intake in Korean men. Acta Cardiol 2002; 57: 5-11.
    • (2002) Acta Cardiol , vol.57 , pp. 5-11
    • Oh, K.W.1    Nam, C.M.2    Jee, S.H.3
  • 281
    • 34548039741 scopus 로고    scopus 로고
    • Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA)
    • Ix JH, Shlipak MG, Katz R et al. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2007; 50: 412-420.
    • (2007) Am J Kidney Dis , vol.50 , pp. 412-420
    • Ix, J.H.1    Shlipak, M.G.2    Katz, R.3
  • 282
    • 0037216095 scopus 로고    scopus 로고
    • Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study
    • Wang AY, Wang M, Woo J et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003; 14: 159-168.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 159-168
    • Wang, A.Y.1    Wang, M.2    Woo, J.3
  • 283
    • 10744219789 scopus 로고    scopus 로고
    • Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients
    • Panuccio V, Tripepi R, Tripepi G et al. Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis 2004; 43: 479-484.
    • (2004) Am J Kidney Dis , vol.43 , pp. 479-484
    • Panuccio, V.1    Tripepi, R.2    Tripepi, G.3
  • 284
    • 0036310682 scopus 로고    scopus 로고
    • Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
    • Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252.
    • (2002) Kidney Int , vol.62 , pp. 245-252
    • Chertow, G.M.1    Burke, S.K.2    Raggi, P.3
  • 285
    • 31644446801 scopus 로고    scopus 로고
    • Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
    • Block GA, Spiegel DM, Ehrlich J et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824.
    • (2005) Kidney Int , vol.68 , pp. 1815-1824
    • Block, G.A.1    Spiegel, D.M.2    Ehrlich, J.3
  • 286
    • 35848951189 scopus 로고    scopus 로고
    • The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer
    • Russo D, Miranda I, Ruocco C et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007; 72: 1255-1261.
    • (2007) Kidney Int , vol.72 , pp. 1255-1261
    • Russo, D.1    Miranda, I.2    Ruocco, C.3
  • 287
    • 43849094954 scopus 로고    scopus 로고
    • A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study
    • Qunibi W, Moustafa M, Muenz LR et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008; 51: 952-965.
    • (2008) Am J Kidney Dis , vol.51 , pp. 952-965
    • Qunibi, W.1    Moustafa, M.2    Muenz, L.R.3
  • 288
    • 55649120437 scopus 로고    scopus 로고
    • Phosphate binder impact on bone remodeling and coronary calcification-results from the BRiC study
    • Barreto DV, Barreto Fde C, de Carvalho AB et al. Phosphate binder impact on bone remodeling and coronary calcification-results from the BRiC study. Nephron Clin Pract 2008; 110: c273-283.
    • (2008) Nephron Clin Pract , vol.110
    • Barreto, D.V.1    Barreto Fde, C.2    de Carvalho, A.B.3
  • 289
    • 52449091565 scopus 로고    scopus 로고
    • Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: Should we CARE-2 avoid them?
    • Floege J. Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them? Nephrol Dial Transplant 2008; 23: 3050-3052.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 3050-3052
    • Floege, J.1
  • 290
    • 34247150319 scopus 로고    scopus 로고
    • Progression of coronary artery calcification in predialysis patients
    • Russo D, Corrao S, Miranda I et al. Progression of coronary artery calcification in predialysis patients. Am J Nephrol 2007; 27: 152-158.
    • (2007) Am J Nephrol , vol.27 , pp. 152-158
    • Russo, D.1    Corrao, S.2    Miranda, I.3
  • 291
    • 0034769791 scopus 로고    scopus 로고
    • Effect of parathyroid hormone levels on carotid intima-media thickness after renal transplantation
    • Suwelack B, Gerhardt U, Witta J et al. Effect of parathyroid hormone levels on carotid intima-media thickness after renal transplantation. Am J Hypertens 2001; 14: 1012-1018.
    • (2001) Am J Hypertens , vol.14 , pp. 1012-1018
    • Suwelack, B.1    Gerhardt, U.2    Witta, J.3
  • 292
    • 55449101447 scopus 로고    scopus 로고
    • Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis
    • Shroff RC, McNair R, Figg N et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748-1757.
    • (2008) Circulation , vol.118 , pp. 1748-1757
    • Shroff, R.C.1    McNair, R.2    Figg, N.3
  • 293
    • 33846702295 scopus 로고    scopus 로고
    • Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency
    • London GM, Guerin AP, Verbeke FH et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007; 18: 613-620.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 613-620
    • London, G.M.1    Guerin, A.P.2    Verbeke, F.H.3
  • 294
    • 58449107131 scopus 로고    scopus 로고
    • 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
    • Matias PJ, Ferreira C, Jorge C et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 611-618
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 611-618
    • Matias, P.J.1    Ferreira, C.2    Jorge, C.3
  • 295
    • 33645458980 scopus 로고    scopus 로고
    • Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol
    • Lopez I, Aguilera-Tejero E, Mendoza FJ et al. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol. J Am Soc Nephrol 2006; 17: 795-804.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 795-804
    • Lopez, I.1    Aguilera-Tejero, E.2    Mendoza, F.J.3
  • 296
    • 58049199370 scopus 로고    scopus 로고
    • A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia
    • Koleganova N, Piecha G, Ritz E et al. A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int 2009; 75: 60-71.
    • (2009) Kidney Int , vol.75 , pp. 60-71
    • Koleganova, N.1    Piecha, G.2    Ritz, E.3
  • 297
    • 67349157697 scopus 로고    scopus 로고
    • The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE(-/-)) mice
    • Ivanovski O, Nikolov IG, Joki N et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE(-/-)) mice. Atherosclerosis 2009; 205: 55-62.
    • (2009) Atherosclerosis , vol.205 , pp. 55-62
    • Ivanovski, O.1    Nikolov, I.G.2    Joki, N.3
  • 298
    • 21044440716 scopus 로고    scopus 로고
    • Systemic cardiovascular disease in uremic rats induced by 1, 25 (OH)2D3
    • Haffner D, Hocher B, Muller D et al. Systemic cardiovascular disease in uremic rats induced by 1, 25 (OH)2D3. J Hypertens 2005; 23: 1067-1075.
    • (2005) J Hypertens , vol.23 , pp. 1067-1075
    • Haffner, D.1    Hocher, B.2    Muller, D.3
  • 299
    • 34548509897 scopus 로고    scopus 로고
    • Differential effects of vitamin D receptor activators on vascular calcification in uremic rats
    • Mizobuchi M, Finch JL, Martin DR et al. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 2007; 72: 709-715.
    • (2007) Kidney Int , vol.72 , pp. 709-715
    • Mizobuchi, M.1    Finch, J.L.2    Martin, D.R.3
  • 300
    • 38149033720 scopus 로고    scopus 로고
    • The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats
    • Lopez I, Mendoza FJ, Aguilera-Tejero E et al. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int 2008; 73: 300-307.
    • (2008) Kidney Int , vol.73 , pp. 300-307
    • Lopez, I.1    Mendoza, F.J.2    Aguilera-Tejero, E.3
  • 301
    • 33846430532 scopus 로고    scopus 로고
    • ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography)
    • Greenland P, Bonow RO, Brundage BH et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 2007; 115: 402-426.
    • (2007) Circulation , vol.115 , pp. 402-426
    • Greenland, P.1    Bonow, R.O.2    Brundage, B.H.3
  • 302
    • 35948942003 scopus 로고    scopus 로고
    • Misleading associations between cholesterol and vascular outcomes in dialysis patients: The need for randomized trials
    • Baigent C, Landray MJ, Wheeler DC. Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials. Semin Dial 2007; 20: 498-503.
    • (2007) Semin Dial , vol.20 , pp. 498-503
    • Baigent, C.1    Landray, M.J.2    Wheeler, D.C.3
  • 303
    • 10744225301 scopus 로고    scopus 로고
    • Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial
    • Nissen SE, Tuzcu EM, Schoenhagen P et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004; 291: 1071-1080.
    • (2004) JAMA , vol.291 , pp. 1071-1080
    • Nissen, S.E.1    Tuzcu, E.M.2    Schoenhagen, P.3
  • 304
    • 0037420492 scopus 로고    scopus 로고
    • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
    • Sever PS, Dahlof B, Poulter NR et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149-1158.
    • (2003) Lancet , vol.361 , pp. 1149-1158
    • Sever, P.S.1    Dahlof, B.2    Poulter, N.R.3
  • 305
    • 15944410609 scopus 로고    scopus 로고
    • Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    • LaRosa JC, Grundy SM, Waters DD et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. NEngl J Med 2005; 352: 1425-1435.
    • (2005) NEngl J Med , vol.352 , pp. 1425-1435
    • LaRosa, J.C.1    Grundy, S.M.2    Waters, D.D.3
  • 306
    • 23044465843 scopus 로고    scopus 로고
    • Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES)
    • Raggi P, Davidson M, Callister TQ et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005; 112: 563-571.
    • (2005) Circulation , vol.112 , pp. 563-571
    • Raggi, P.1    Davidson, M.2    Callister, T.Q.3
  • 307
    • 33644866420 scopus 로고    scopus 로고
    • Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: A multicenter, randomized, double-blind trial
    • Schmermund A, Achenbach S, Budde T et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation 2006; 113: 427-437.
    • (2006) Circulation , vol.113 , pp. 427-437
    • Schmermund, A.1    Achenbach, S.2    Budde, T.3
  • 308
    • 0037407617 scopus 로고    scopus 로고
    • Study of Heart and Renal Protection (SHARP)
    • Baigent C, Landry M. Study of Heart and Renal Protection (SHARP). Kidney Int 2003; 63 (Suppl 84): S207-210.
    • (2003) Kidney Int , vol.63 , Issue.SUPPL. 84
    • Baigent, C.1    Landry, M.2
  • 309
    • 63849163945 scopus 로고    scopus 로고
    • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    • Fellström BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407.
    • (2009) N Engl J Med , vol.360 , pp. 1395-1407
    • Fellström, B.C.1    Jardine, A.G.2    Schmieder, R.E.3
  • 310
    • 34547219351 scopus 로고    scopus 로고
    • Phosphate metabolism in the setting of chronic kidney disease: Significance and recommendations for treatment
    • Kestenbaum B. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment. Semin Dial 2007; 20: 286-294.
    • (2007) Semin Dial , vol.20 , pp. 286-294
    • Kestenbaum, B.1
  • 311
    • 33947599161 scopus 로고    scopus 로고
    • Phosphate restriction in diet therapy
    • Takeda E, Yamamoto H, Nishida Y et al. Phosphate restriction in diet therapy. Contrib Nephrol 2007; 155: 113-124.
    • (2007) Contrib Nephrol , vol.155 , pp. 113-124
    • Takeda, E.1    Yamamoto, H.2    Nishida, Y.3
  • 312
    • 37749016095 scopus 로고    scopus 로고
    • A comparative review of the efficacy and safety of established phosphate binders: Calcium, sevelamer, and lanthanum carbonate
    • Sprague SM. A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate. Curr Med Res Opin 2007; 23: 3167-3175.
    • (2007) Curr Med Res Opin , vol.23 , pp. 3167-3175
    • Sprague, S.M.1
  • 313
    • 33846868821 scopus 로고    scopus 로고
    • Phosphorus balance and mineral metabolism with 3 h daily hemodialysis
    • Ayus JC, Achinger SG, Mizani MR et al. Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int 2007; 71: 336-342.
    • (2007) Kidney Int , vol.71 , pp. 336-342
    • Ayus, J.C.1    Achinger, S.G.2    Mizani, M.R.3
  • 314
    • 34548772315 scopus 로고    scopus 로고
    • Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial
    • Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298: 1291-1299.
    • (2007) JAMA , vol.298 , pp. 1291-1299
    • Culleton, B.F.1    Walsh, M.2    Klarenbach, S.W.3
  • 315
    • 0034836578 scopus 로고    scopus 로고
    • Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients
    • Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 2131-2138
    • Ganesh, S.K.1    Stack, A.G.2    Levin, N.W.3
  • 316
    • 20544433192 scopus 로고    scopus 로고
    • Serum phosphate levels and mortality risk among people with chronic kidney disease
    • Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005; 16: 520-528.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 520-528
    • Kestenbaum, B.1    Sampson, J.N.2    Rudser, K.D.3
  • 317
    • 0031920748 scopus 로고    scopus 로고
    • Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
    • Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617.
    • (1998) Am J Kidney Dis , vol.31 , pp. 607-617
    • Block, G.A.1    Hulbert-Shearon, T.E.2    Levin, N.W.3
  • 319
    • 0028858407 scopus 로고
    • Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D
    • Naveh-Many T, Rahamimov R, Livni N et al. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995; 96: 1786-1793.
    • (1995) J Clin Invest , vol.96 , pp. 1786-1793
    • Naveh-Many, T.1    Rahamimov, R.2    Livni, N.3
  • 320
    • 0030012579 scopus 로고    scopus 로고
    • Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro
    • Almaden Y, Canalejo A, Hernandez A et al. Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 1996; 11: 970-976.
    • (1996) J Bone Miner Res , vol.11 , pp. 970-976
    • Almaden, Y.1    Canalejo, A.2    Hernandez, A.3
  • 321
    • 0017339088 scopus 로고
    • The role of phosphate and other factors on the pathogenesis of renal osteodystrophy
    • Slatopolsky E, Rutherford WE, Martin K et al. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy. Adv Exp Med Biol 1977; 81: 467-475.
    • (1977) Adv Exp Med Biol , vol.81 , pp. 467-475
    • Slatopolsky, E.1    Rutherford, W.E.2    Martin, K.3
  • 322
    • 39749097199 scopus 로고    scopus 로고
    • Role of vitamin D deficiency in chronic kidney disease
    • Gal-Moscovici A, Sprague SM. Role of vitamin D deficiency in chronic kidney disease. J Bone Miner Res 2007; 22 (Suppl 2): V91-94.
    • (2007) J Bone Miner Res , vol.22 , Issue.SUPPL. 2
    • Gal-Moscovici, A.1    Sprague, S.M.2
  • 323
    • 0043037220 scopus 로고    scopus 로고
    • Vascular calcification: In vitro evidence for the role of inorganic phosphate
    • Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 14: S300-304.
    • (2003) J Am Soc Nephrol , vol.14
    • Giachelli, C.M.1
  • 324
    • 34248522825 scopus 로고    scopus 로고
    • Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community
    • Dhingra R, Sullivan LM, Fox CS et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-885.
    • (2007) Arch Intern Med , vol.167 , pp. 879-885
    • Dhingra, R.1    Sullivan, L.M.2    Fox, C.S.3
  • 325
    • 27444436252 scopus 로고    scopus 로고
    • Relation between serum phosphate level and cardiovascular event rate in people with coronary disease
    • Tonelli M, Sacks F, Pfeffer M et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627-2633.
    • (2005) Circulation , vol.112 , pp. 2627-2633
    • Tonelli, M.1    Sacks, F.2    Pfeffer, M.3
  • 326
    • 23944460805 scopus 로고    scopus 로고
    • Relationship of phosphorus and calcium-phosphorus product with mortality in CKD
    • Menon V, Greene T, Pereira AA et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis 2005; 46: 455-463.
    • (2005) Am J Kidney Dis , vol.46 , pp. 455-463
    • Menon, V.1    Greene, T.2    Pereira, A.A.3
  • 327
    • 27144485353 scopus 로고    scopus 로고
    • The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association with mortality in dialysis patients
    • Noordzij M, Korevaar JC, Boeschoten EW et al. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 2005; 46: 925-932.
    • (2005) Am J Kidney Dis , vol.46 , pp. 925-932
    • Noordzij, M.1    Korevaar, J.C.2    Boeschoten, E.W.3
  • 328
    • 33745210682 scopus 로고    scopus 로고
    • Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
    • Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780.
    • (2006) Kidney Int , vol.70 , pp. 771-780
    • Kalantar-Zadeh, K.1    Kuwae, N.2    Regidor, D.L.3
  • 329
    • 18144402703 scopus 로고    scopus 로고
    • Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
    • Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187.
    • (2005) Kidney Int , vol.67 , pp. 1179-1187
    • Young, E.W.1    Albert, J.M.2    Satayathum, S.3
  • 330
    • 34250742377 scopus 로고    scopus 로고
    • Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study
    • Kimata N, Albert JM, Akiba T et al. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int 2007; 11: 340-348.
    • (2007) Hemodial Int , vol.11 , pp. 340-348
    • Kimata, N.1    Albert, J.M.2    Akiba, T.3
  • 331
    • 0032737436 scopus 로고    scopus 로고
    • Effect of phosphate on parathyroid hormone secretion in vivo
    • Estepa JC, Aguilera-Tejero E, Lopez I et al. Effect of phosphate on parathyroid hormone secretion in vivo. J Bone Miner Res 1999; 14: 1848-1854.
    • (1999) J Bone Miner Res , vol.14 , pp. 1848-1854
    • Estepa, J.C.1    Aguilera-Tejero, E.2    Lopez, I.3
  • 332
    • 0034947319 scopus 로고    scopus 로고
    • Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate
    • Roussanne MC, Lieberherr M, Souberbielle JC et al. Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate. Eur J Clin Invest 2001; 31: 610-616.
    • (2001) Eur J Clin Invest , vol.31 , pp. 610-616
    • Roussanne, M.C.1    Lieberherr, M.2    Souberbielle, J.C.3
  • 333
    • 0034730291 scopus 로고    scopus 로고
    • Phosphate regulation of vascular smooth muscle cell calcification
    • Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-17.
    • (2000) Circ Res , vol.87
    • Jono, S.1    McKee, M.D.2    Murry, C.E.3
  • 334
    • 33749355680 scopus 로고    scopus 로고
    • Review of dialysate calcium concentration in hemodialysis
    • Toussaint N, Cooney P, Kerr PG. Review of dialysate calcium concentration in hemodialysis. Hemodial Int 2006; 10: 326-337.
    • (2006) Hemodial Int , vol.10 , pp. 326-337
    • Toussaint, N.1    Cooney, P.2    Kerr, P.G.3
  • 335
    • 38749091696 scopus 로고    scopus 로고
    • Calcium balance during hemodialysis
    • McIntyre CW. Calcium balance during hemodialysis. Semin Dial 2008; 21: 38-42.
    • (2008) Semin Dial , vol.21 , pp. 38-42
    • McIntyre, C.W.1
  • 336
    • 0026040622 scopus 로고
    • Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate
    • Hou SH, Zhao J, Ellman CF et al. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 1991; 18: 217-224.
    • (1991) Am J Kidney Dis , vol.18 , pp. 217-224
    • Hou, S.H.1    Zhao, J.2    Ellman, C.F.3
  • 337
    • 0027415634 scopus 로고
    • Calcium kinetics and the long-term effects of lowering dialysate calcium concentration
    • Argiles A, Kerr PG, Canaud B et al. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int 1993; 43: 630-640.
    • (1993) Kidney Int , vol.43 , pp. 630-640
    • Argiles, A.1    Kerr, P.G.2    Canaud, B.3
  • 338
    • 30644478153 scopus 로고    scopus 로고
    • Calcium exposure and removal in chronic hemodialysis patients
    • Sigrist M, McIntyre CW. Calcium exposure and removal in chronic hemodialysis patients. JRen Nutr 2006; 16: 41-46.
    • (2006) JRen Nutr , vol.16 , pp. 41-46
    • Sigrist, M.1    McIntyre, C.W.2
  • 339
    • 0022636886 scopus 로고
    • Blood pressure response to changes in serum ionized calcium during hemodialysis
    • Maynard JC, Cruz C, Kleerekoper M et al. Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med 1986; 104: 358-361.
    • (1986) Ann Intern Med , vol.104 , pp. 358-361
    • Maynard, J.C.1    Cruz, C.2    Kleerekoper, M.3
  • 340
    • 0031837404 scopus 로고    scopus 로고
    • Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients
    • van der Sande FM, Cheriex EC, van Kuijk WH et al. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients. Am J Kidney Dis 1998; 32: 125-131.
    • (1998) Am J Kidney Dis , vol.32 , pp. 125-131
    • van der Sande, F.M.1    Cheriex, E.C.2    van Kuijk, W.H.3
  • 341
    • 0029797567 scopus 로고    scopus 로고
    • Systemic aluminum toxicity: Effects on bone, hematopoietic tissue, and kidney
    • Jeffery EH, Abreo K, Burgess E et al. Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J Toxicol Environ Health 1996; 48: 649-665.
    • (1996) J Toxicol Environ Health , vol.48 , pp. 649-665
    • Jeffery, E.H.1    Abreo, K.2    Burgess, E.3
  • 342
    • 0019391474 scopus 로고
    • Aluminum toxicity in relation to kidney disorders
    • King SW, Savory J, Wills MR. Aluminum toxicity in relation to kidney disorders. Ann Clin Lab Sci 1981; 11: 337-342.
    • (1981) Ann Clin Lab Sci , vol.11 , pp. 337-342
    • King, S.W.1    Savory, J.2    Wills, M.R.3
  • 343
    • 4444227474 scopus 로고    scopus 로고
    • Long-term comparison of a calcium-free phosphate binder and calcium carbonate-phosphorus metabolism and cardiovascular calcification
    • Braun J, Asmus HG, Holzer H et al. Long-term comparison of a calcium-free phosphate binder and calcium carbonate-phosphorus metabolism and cardiovascular calcification. Clin Nephrol 2004; 62: 104-115.
    • (2004) Clin Nephrol , vol.62 , pp. 104-115
    • Braun, J.1    Asmus, H.G.2    Holzer, H.3
  • 344
    • 26444492201 scopus 로고    scopus 로고
    • Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
    • Asmus HG, Braun J, Krause R et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 2005; 20: 1653-1661.
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 1653-1661
    • Asmus, H.G.1    Braun, J.2    Krause, R.3
  • 345
    • 3242696702 scopus 로고    scopus 로고
    • Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer
    • Raggi P, Bommer J, Chertow GM. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. J Heart Valve Dis 2004; 13: 134-141.
    • (2004) J Heart Valve Dis , vol.13 , pp. 134-141
    • Raggi, P.1    Bommer, J.2    Chertow, G.M.3
  • 346
    • 17644395611 scopus 로고    scopus 로고
    • Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis
    • Raggi P, James G, Burke SK et al. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. J Bone Miner Res 2005; 20: 764-772.
    • (2005) J Bone Miner Res , vol.20 , pp. 764-772
    • Raggi, P.1    James, G.2    Burke, S.K.3
  • 347
    • 0027991769 scopus 로고
    • Evidence for abnormal calcium homeostasis in patients with adynamic bone disease
    • Kurz P, Monier-Faugere MC, Bognar B et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994; 46: 855-861.
    • (1994) Kidney Int , vol.46 , pp. 855-861
    • Kurz, P.1    Monier-Faugere, M.C.2    Bognar, B.3
  • 348
    • 18744362733 scopus 로고    scopus 로고
    • Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: A 6-month, randomized, comparative trial versus calcium carbonate
    • Hutchison AJ, Maes B, Vanwalleghem J et al. Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate. Nephron Clin Pract 2005; 100: c8-19.
    • (2005) Nephron Clin Pract , vol.100
    • Hutchison, A.J.1    Maes, B.2    Vanwalleghem, J.3
  • 349
    • 33644786844 scopus 로고    scopus 로고
    • Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: Safety and efficacy in chronic maintenance hemodialysis patients
    • Finn WF. Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients. Clin Nephrol 2006; 65: 191-202.
    • (2006) Clin Nephrol , vol.65 , pp. 191-202
    • Finn, W.F.1
  • 350
    • 0036224574 scopus 로고    scopus 로고
    • Intestinal absorption of aluminium in renal failure
    • Drueke TB. Intestinal absorption of aluminium in renal failure. Nephrol Dial Transplant 2002; 17 (Suppl 2): 13-16.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 2 , pp. 13-16
    • Drueke, T.B.1
  • 351
    • 0026017322 scopus 로고
    • Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus
    • Zeller K, Whittaker E, Sullivan L et al. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 78-84.
    • (1991) N Engl J Med , vol.324 , pp. 78-84
    • Zeller, K.1    Whittaker, E.2    Sullivan, L.3
  • 352
    • 0026788096 scopus 로고
    • Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy
    • Lafage MH, Combe C, Fournier A et al. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy. Kidney Int 1992; 42: 1217-1225.
    • (1992) Kidney Int , vol.42 , pp. 1217-1225
    • Lafage, M.H.1    Combe, C.2    Fournier, A.3
  • 353
    • 0033018313 scopus 로고    scopus 로고
    • Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction
    • Lafage-Proust MH, Combe C, Barthe N et al. Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction. J Clin Endocrinol Metab 1999; 84: 512-519.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 512-519
    • Lafage-Proust, M.H.1    Combe, C.2    Barthe, N.3
  • 354
    • 33645218040 scopus 로고    scopus 로고
    • A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD
    • Pieper AK, Haffner D, Hoppe B et al. A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 2006; 47: 625-635.
    • (2006) Am J Kidney Dis , vol.47 , pp. 625-635
    • Pieper, A.K.1    Haffner, D.2    Hoppe, B.3
  • 355
    • 36049029061 scopus 로고    scopus 로고
    • Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
    • Tonelli M, Wiebe N, Culleton B et al. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients. Nephrol Dial Transplant 2007; 22: 2856-2866.
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 2856-2866
    • Tonelli, M.1    Wiebe, N.2    Culleton, B.3
  • 356
    • 33846526233 scopus 로고    scopus 로고
    • Cognitive function in stage 5 chronic kidney disease patients on hemodialysis: No adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy
    • Altmann P, Barnett ME, Finn WF. Cognitive function in stage 5 chronic kidney disease patients on hemodialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy. Kidney Int 2007; 71: 252-259.
    • (2007) Kidney Int , vol.71 , pp. 252-259
    • Altmann, P.1    Barnett, M.E.2    Finn, W.F.3
  • 357
    • 10744227063 scopus 로고    scopus 로고
    • The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients
    • Chertow GM, Raggi P, McCarthy JT et al. The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. Am J Nephrol 2003; 23: 307-314.
    • (2003) Am J Nephrol , vol.23 , pp. 307-314
    • Chertow, G.M.1    Raggi, P.2    McCarthy, J.T.3
  • 358
    • 0027203235 scopus 로고
    • The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine
    • Brown AJ, Finch J, Grieff M et al. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Endocrinology 1993; 133: 1158-1164.
    • (1993) Endocrinology , vol.133 , pp. 1158-1164
    • Brown, A.J.1    Finch, J.2    Grieff, M.3
  • 359
    • 0036380963 scopus 로고    scopus 로고
    • Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats
    • Slatopolsky E, Cozzolino M, Finch JL. Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats. Kidney Int 2002; 62: 1277-1284.
    • (2002) Kidney Int , vol.62 , pp. 1277-1284
    • Slatopolsky, E.1    Cozzolino, M.2    Finch, J.L.3
  • 360
    • 30944448050 scopus 로고    scopus 로고
    • Differential effects of Vitamin D analogs on bone formation and resorption
    • Nakane M, Fey TA, Dixon DB et al. Differential effects of Vitamin D analogs on bone formation and resorption. J Steroid Biochem Mol Biol 2006; 98: 72-77.
    • (2006) J Steroid Biochem Mol Biol , vol.98 , pp. 72-77
    • Nakane, M.1    Fey, T.A.2    Dixon, D.B.3
  • 361
    • 34548274602 scopus 로고    scopus 로고
    • Differential effects of vitamin D analogs on vascular calcification
    • Cardus A, Panizo S, Parisi E et al. Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 2007; 22: 860-866.
    • (2007) J Bone Miner Res , vol.22 , pp. 860-866
    • Cardus, A.1    Panizo, S.2    Parisi, E.3
  • 362
    • 34547410327 scopus 로고    scopus 로고
    • Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice
    • Fryer RM, Rakestraw PA, Nakane M et al. Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice. Nephron 2007; 106: 76-81.
    • (2007) Nephron , vol.106 , pp. 76-81
    • Fryer, R.M.1    Rakestraw, P.A.2    Nakane, M.3
  • 363
    • 34447647437 scopus 로고    scopus 로고
    • 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alphahydroxylated vitamin D analogue
    • Segersten U, Holm PK, Bjorklund P et al. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alphahydroxylated vitamin D analogue. Breast Cancer Res 2005; 7: R980-R986.
    • (2005) Breast Cancer Res , vol.7
    • Segersten, U.1    Holm, P.K.2    Bjorklund, P.3
  • 364
    • 33845663542 scopus 로고    scopus 로고
    • Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells
    • van Driel M, Koedam M, Buurman CJ et al. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J 2006; 20: 2417-2419.
    • (2006) FASEB J , vol.20 , pp. 2417-2419
    • van Driel, M.1    Koedam, M.2    Buurman, C.J.3
  • 365
    • 17144398824 scopus 로고    scopus 로고
    • 25-hydroxyvitamin D3-1alphahydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds
    • Somjen D, Weisman Y, Kohen F et al. 25-hydroxyvitamin D3-1alphahydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005; 111: 1666-1671.
    • (2005) Circulation , vol.111 , pp. 1666-1671
    • Somjen, D.1    Weisman, Y.2    Kohen, F.3
  • 366
    • 0036075861 scopus 로고    scopus 로고
    • 25-hydroxyvitamin D(3)-1alphahydroxylase expression in normal and pathological parathyroid glands
    • Segersten U, Correa P, Hewison M et al. 25-hydroxyvitamin D(3)-1alphahydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 2002; 87: 2967-2972.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 2967-2972
    • Segersten, U.1    Correa, P.2    Hewison, M.3
  • 367
    • 0020675794 scopus 로고
    • Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue
    • Brown EM. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 1983; 56: 572-581.
    • (1983) J Clin Endocrinol Metab , vol.56 , pp. 572-581
    • Brown, E.M.1
  • 368
    • 0027765508 scopus 로고
    • Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid
    • Brown EM, Gamba G, Riccardi D et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580.
    • (1993) Nature , vol.366 , pp. 575-580
    • Brown, E.M.1    Gamba, G.2    Riccardi, D.3
  • 369
    • 33846429183 scopus 로고    scopus 로고
    • Clinical lessons from the calcium-sensing receptor
    • Brown EM. Clinical lessons from the calcium-sensing receptor. Nat Clin Pract Endocrinol Metab 2007; 3: 122-133.
    • (2007) Nat Clin Pract Endocrinol Metab , vol.3 , pp. 122-133
    • Brown, E.M.1
  • 370
    • 33845760490 scopus 로고    scopus 로고
    • Molecular basis of parathyroid hyperplasia
    • Dusso AS, Arcidiacono MV, Sato T et al. Molecular basis of parathyroid hyperplasia. J Ren Nutr 2007; 17: 45-47.
    • (2007) J Ren Nutr , vol.17 , pp. 45-47
    • Dusso, A.S.1    Arcidiacono, M.V.2    Sato, T.3
  • 371
    • 39149101470 scopus 로고    scopus 로고
    • Vascular events in healthy older women receiving calcium supplementation: Randomised controlled trial
    • Bolland MJ, Barber PA, Doughty RN et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008; 336: 262-266.
    • (2008) BMJ , vol.336 , pp. 262-266
    • Bolland, M.J.1    Barber, P.A.2    Doughty, R.N.3
  • 372
    • 33847110738 scopus 로고    scopus 로고
    • Calcium/vitamin D supplementation and cardiovascular events
    • Hsia J, Heiss G, Ren H et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846-854.
    • (2007) Circulation , vol.115 , pp. 846-854
    • Hsia, J.1    Heiss, G.2    Ren, H.3
  • 373
    • 64049103456 scopus 로고    scopus 로고
    • Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: A randomized trial
    • Sprague SM, Abboud H, Qiu P et al. Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 178-185
    • Sprague, S.M.1    Abboud, H.2    Qiu, P.3
  • 374
    • 60149095573 scopus 로고    scopus 로고
    • The effect of combined calcium and vitamin D(3) supplementation on serum intact parathyroid hormone in moderate CKD
    • Kooienga L, Fried L, Scragg R et al. The effect of combined calcium and vitamin D(3) supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis 2009; 53: 408-416.
    • (2009) Am J Kidney Dis , vol.53 , pp. 408-416
    • Kooienga, L.1    Fried, L.2    Scragg, R.3
  • 375
    • 33847669753 scopus 로고    scopus 로고
    • Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease
    • Zisman AL, Hristova M, Ho LT et al. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 2007; 27: 36-43.
    • (2007) Am J Nephrol , vol.27 , pp. 36-43
    • Zisman, A.L.1    Hristova, M.2    Ho, L.T.3
  • 376
    • 1942466552 scopus 로고    scopus 로고
    • Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4
    • Coburn JW, Maung HM, Elangovan L et al. Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. Am J Kidney Dis 2004; 43: 877-890.
    • (2004) Am J Kidney Dis , vol.43 , pp. 877-890
    • Coburn, J.W.1    Maung, H.M.2    Elangovan, L.3
  • 377
    • 31044455712 scopus 로고    scopus 로고
    • Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD
    • Coyne D, Acharya M, Qiu P et al. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 2006; 47: 263-276.
    • (2006) Am J Kidney Dis , vol.47 , pp. 263-276
    • Coyne, D.1    Acharya, M.2    Qiu, P.3
  • 378
    • 0028912597 scopus 로고
    • Effects of 24R, 25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: Biochemistry and histomorphometry of cancellous bone
    • Birkenhäger-Frenkel DH, Pols HA, Zeelenberg J et al. Effects of 24R, 25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone. J Bone Miner Res 1995; 10: 197-204.
    • (1995) J Bone Miner Res , vol.10 , pp. 197-204
    • Birkenhäger-Frenkel, D.H.1    Pols, H.A.2    Zeelenberg, J.3
  • 379
    • 58349117276 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis
    • Chonchol M, Locatelli F, Abboud HE et al. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis 2009; 53: 197-207.
    • (2009) Am J Kidney Dis , vol.53 , pp. 197-207
    • Chonchol, M.1    Locatelli, F.2    Abboud, H.E.3
  • 380
    • 1542288794 scopus 로고    scopus 로고
    • Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes
    • Stevens LA, Djurdjev O, Cardew S et al. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004; 15: 770-779.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 770-779
    • Stevens, L.A.1    Djurdjev, O.2    Cardew, S.3
  • 381
    • 85205836180 scopus 로고    scopus 로고
    • Strippoli GF, Tong A, Palmer SC et al. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev 2006: CD006254
    • Strippoli GF, Tong A, Palmer SC et al. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Syst Rev 2006: CD006254.
  • 382
    • 20844459261 scopus 로고    scopus 로고
    • Activated injectable vitamin D and hemodialysis survival: A historical cohort study
    • Teng M, Wolf M, Ofsthun MN et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16: 1115-1125.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 1115-1125
    • Teng, M.1    Wolf, M.2    Ofsthun, M.N.3
  • 383
    • 33750576187 scopus 로고    scopus 로고
    • Mortality risk among hemodialysis patients receiving different vitamin D analogs
    • Tentori F, Hunt WC, Stidley CA et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865.
    • (2006) Kidney Int , vol.70 , pp. 1858-1865
    • Tentori, F.1    Hunt, W.C.2    Stidley, C.A.3
  • 384
    • 0042343804 scopus 로고    scopus 로고
    • Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
    • Teng M, Wolf M, Lowrie E et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. NEngl J Med 2003; 349: 446-456.
    • (2003) NEngl J Med , vol.349 , pp. 446-456
    • Teng, M.1    Wolf, M.2    Lowrie, E.3
  • 385
    • 60749091527 scopus 로고    scopus 로고
    • The survival advantage for haemodialysis patients taking vitamin D is questioned: Findings from the Dialysis Outcomes and Practice Patterns Study
    • Tentori F, Albert JM, Young EW et al. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2009; 24: 963-972.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 963-972
    • Tentori, F.1    Albert, J.M.2    Young, E.W.3
  • 386
    • 29144431716 scopus 로고    scopus 로고
    • Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
    • Cunningham J, Danese M, Olson K et al. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 2005; 68: 1793-1800.
    • (2005) Kidney Int , vol.68 , pp. 1793-1800
    • Cunningham, J.1    Danese, M.2    Olson, K.3
  • 387
    • 11144353767 scopus 로고    scopus 로고
    • Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
    • Block GA, Martin KJ, de Francisco AL et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004; 350: 1516-1525.
    • (2004) N Engl J Med , vol.350 , pp. 1516-1525
    • Block, G.A.1    Martin, K.J.2    de Francisco, A.L.3
  • 388
    • 20544460709 scopus 로고    scopus 로고
    • Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study
    • Lindberg JS, Culleton B, Wong G et al. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol 2005; 16: 800-807.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 800-807
    • Lindberg, J.S.1    Culleton, B.2    Wong, G.3
  • 389
    • 42049115865 scopus 로고    scopus 로고
    • An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism
    • Malluche HH, Monier-Faugere MC, Wang G et al. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol 2008; 69: 269-278.
    • (2008) Clin Nephrol , vol.69 , pp. 269-278
    • Malluche, H.H.1    Monier-Faugere, M.C.2    Wang, G.3
  • 390
    • 49649129489 scopus 로고    scopus 로고
    • Vitamin D deficiency and associated factors in hemodialysis patients
    • Jean G, Charra B, Chazot C. Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr 2008; 18: 395-399.
    • (2008) J Ren Nutr , vol.18 , pp. 395-399
    • Jean, G.1    Charra, B.2    Chazot, C.3
  • 391
    • 4344601923 scopus 로고    scopus 로고
    • Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: A randomized prospective multicentre trial
    • Hayashi M, Tsuchiya Y, Itaya Y et al. Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial. Nephrol Dial Transplant 2004; 19: 2067-2073.
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 2067-2073
    • Hayashi, M.1    Tsuchiya, Y.2    Itaya, Y.3
  • 392
    • 0037378444 scopus 로고    scopus 로고
    • Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
    • Sprague SM, Llach F, Amdahl M et al. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 2003; 63: 1483-1490.
    • (2003) Kidney Int , vol.63 , pp. 1483-1490
    • Sprague, S.M.1    Llach, F.2    Amdahl, M.3
  • 394
    • 0028147160 scopus 로고
    • Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients
    • Liou HH, Chiang SS, Huang TP et al. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients. Miner Electrolyte Metab 1994; 20: 97-102.
    • (1994) Miner Electrolyte Metab , vol.20 , pp. 97-102
    • Liou, H.H.1    Chiang, S.S.2    Huang, T.P.3
  • 395
    • 19944430161 scopus 로고    scopus 로고
    • Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl
    • Moe SM, Chertow GM, Coburn JW et al. Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 2005; 67: 760-771.
    • (2005) Kidney Int , vol.67 , pp. 760-771
    • Moe, S.M.1    Chertow, G.M.2    Coburn, J.W.3
  • 396
    • 58149334973 scopus 로고    scopus 로고
    • Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: The ACHIEVE study results
    • Fishbane S, Shapiro WB, Corry DB et al. Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. Clin J Am Soc Nephrol 2008; 3: 1718-1725.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1718-1725
    • Fishbane, S.1    Shapiro, W.B.2    Corry, D.B.3
  • 397
    • 21244475660 scopus 로고    scopus 로고
    • Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis
    • Greenbaum LA, Grenda R, Qiu P et al. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Pediatr Nephrol 2005; 20: 622-630.
    • (2005) Pediatr Nephrol , vol.20 , pp. 622-630
    • Greenbaum, L.A.1    Grenda, R.2    Qiu, P.3
  • 398
    • 0031908949 scopus 로고    scopus 로고
    • Intermittent calcitriol therapy and growth in children with chronic renal failure
    • Kuizon BD, Salusky IB. Intermittent calcitriol therapy and growth in children with chronic renal failure. Miner Electrolyte Metab 1998; 24: 290-295.
    • (1998) Miner Electrolyte Metab , vol.24 , pp. 290-295
    • Kuizon, B.D.1    Salusky, I.B.2
  • 399
    • 10744224831 scopus 로고    scopus 로고
    • Growth in children with chronic renal failure on intermittent versus daily calcitriol
    • Schmitt CP, Ardissino G, Testa S et al. Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 2003; 18: 440-444.
    • (2003) Pediatr Nephrol , vol.18 , pp. 440-444
    • Schmitt, C.P.1    Ardissino, G.2    Testa, S.3
  • 400
    • 34249081159 scopus 로고    scopus 로고
    • Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis
    • Greenbaum LA, Benador N, Goldstein SL et al. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. Am J Kidney Dis 2007; 49: 814-823.
    • (2007) Am J Kidney Dis , vol.49 , pp. 814-823
    • Greenbaum, L.A.1    Benador, N.2    Goldstein, S.L.3
  • 401
    • 0037850070 scopus 로고    scopus 로고
    • Parathyroidectomy: Whom and when?
    • Jofre R, Lopez Gomez JM, Menarguez J et al. Parathyroidectomy: whom and when? Kidney Int 2003; 63 (Suppl 85): S97-100.
    • (2003) Kidney Int , vol.63 , Issue.SUPPL. 85
    • Jofre, R.1    Lopez Gomez, J.M.2    Menarguez, J.3
  • 402
    • 0029053693 scopus 로고
    • Results of surgical treatment of renal hyperparathyroidism
    • Neonakis E, Wheeler MH, Krishnan H et al. Results of surgical treatment of renal hyperparathyroidism. Arch Surg 1995; 130: 643-648.
    • (1995) Arch Surg , vol.130 , pp. 643-648
    • Neonakis, E.1    Wheeler, M.H.2    Krishnan, H.3
  • 403
    • 0035164535 scopus 로고    scopus 로고
    • Secondary and tertiary hyperparathyroidism: Causes of recurrent disease after 446 parathyroidectomies
    • Gasparri G, Camandona M, Abbona GC et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Sur 2001; 233: 65-69.
    • (2001) Ann Sur , vol.233 , pp. 65-69
    • Gasparri, G.1    Camandona, M.2    Abbona, G.C.3
  • 404
    • 0026936519 scopus 로고
    • Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients
    • Gagne ER, Urena P, Leite-Silva S et al. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992; 3: 1008-1017.
    • (1992) J Am Soc Nephrol , vol.3 , pp. 1008-1017
    • Gagne, E.R.1    Urena, P.2    Leite-Silva, S.3
  • 405
    • 21644435007 scopus 로고    scopus 로고
    • Survival following parathyroidectomy among United States dialysis patients
    • Kestenbaum B, Andress DL, Schwartz SM et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int 2004; 66: 2010-2016.
    • (2004) Kidney Int , vol.66 , pp. 2010-2016
    • Kestenbaum, B.1    Andress, D.L.2    Schwartz, S.M.3
  • 406
    • 34248144514 scopus 로고    scopus 로고
    • Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism
    • Trombetti A, Stoermann C, Robert JH et al. Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism. World J Sur 2007; 31: 1014-1021.
    • (2007) World J Sur , vol.31 , pp. 1014-1021
    • Trombetti, A.1    Stoermann, C.2    Robert, J.H.3
  • 407
    • 0023193563 scopus 로고
    • Heterogeneity of age-related fractures: Implications for epidemiology
    • Melton III LJ, Cummings SR. Heterogeneity of age-related fractures: implications for epidemiology. Bone Miner 1987; 2: 321-331.
    • (1987) Bone Miner , vol.2 , pp. 321-331
    • Melton III, L.J.1    Cummings, S.R.2
  • 408
    • 52949118450 scopus 로고    scopus 로고
    • Theoretical implications of the biomechanical fracture threshold
    • Keaveny TM, Bouxsein ML. Theoretical implications of the biomechanical fracture threshold. J Bone Miner Res 2008; 23: 1541-7.
    • (2008) J Bone Miner Res , vol.23 , pp. 1541-1547
    • Keaveny, T.M.1    Bouxsein, M.L.2
  • 409
    • 0035692322 scopus 로고    scopus 로고
    • Assessment of bone quality, quantity, and turnover with multiple methodologies at multiple skeletal sites
    • Chesnut C, Majumdar S, Gardner J et al. Assessment of bone quality, quantity, and turnover with multiple methodologies at multiple skeletal sites. Adv Exp Med Biol 2001; 496: 95-97.
    • (2001) Adv Exp Med Biol , vol.496 , pp. 95-97
    • Chesnut, C.1    Majumdar, S.2    Gardner, J.3
  • 410
    • 34547189101 scopus 로고    scopus 로고
    • Renal osteodystrophy, phosphate homeostasis, and vascular calcification
    • Hruska KA, Saab G, Mathew S et al. Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial 2007; 20: 309-315.
    • (2007) Semin Dial , vol.20 , pp. 309-315
    • Hruska, K.A.1    Saab, G.2    Mathew, S.3
  • 411
    • 0029983016 scopus 로고    scopus 로고
    • Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients-retrospective analysis of 1429 iliac crest biopsies
    • Ballanti P, Wedard BM, Bonucci E. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients-retrospective analysis of 1429 iliac crest biopsies. Nephrol Dial Transplant 1996; 11: 663-667.
    • (1996) Nephrol Dial Transplant , vol.11 , pp. 663-667
    • Ballanti, P.1    Wedard, B.M.2    Bonucci, E.3
  • 412
    • 1842867053 scopus 로고    scopus 로고
    • Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial
    • Anderson GL, Limacher M, Assaf AR et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-1712.
    • (2004) JAMA , vol.291 , pp. 1701-1712
    • Anderson, G.L.1    Limacher, M.2    Assaf, A.R.3
  • 413
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial
    • Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
    • (2002) JAMA , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 414
    • 34250696907 scopus 로고    scopus 로고
    • Estrogen therapy and coronary-artery calcification
    • Manson JE, Allison MA, Rossouw JE et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007; 356: 2591-2602.
    • (2007) N Engl J Med , vol.356 , pp. 2591-2602
    • Manson, J.E.1    Allison, M.A.2    Rossouw, J.E.3
  • 415
    • 0014620810 scopus 로고
    • Serum gonadotropin and testosterone levels in uremic males undergoing intermittent dialysis
    • Guevara A, Vidt D, Hallberg MC et al. Serum gonadotropin and testosterone levels in uremic males undergoing intermittent dialysis. Metabolism 1969; 18: 1062-1066.
    • (1969) Metabolism , vol.18 , pp. 1062-1066
    • Guevara, A.1    Vidt, D.2    Hallberg, M.C.3
  • 416
    • 13244279380 scopus 로고    scopus 로고
    • Medication use patterns for osteoporosis: An assessment of guidelines, treatment rates, and quality improvement interventions
    • Solomon DH, Morris C, Cheng H et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc 2005; 80: 194-202.
    • (2005) Mayo Clin Proc , vol.80 , pp. 194-202
    • Solomon, D.H.1    Morris, C.2    Cheng, H.3
  • 417
    • 17844408127 scopus 로고    scopus 로고
    • Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women
    • Schousboe JT, Nyman JA, Kane RL et al. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 2005; 142: 734-741.
    • (2005) Ann Intern Med , vol.142 , pp. 734-741
    • Schousboe, J.T.1    Nyman, J.A.2    Kane, R.L.3
  • 418
    • 39349086278 scopus 로고    scopus 로고
    • Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
    • MacLean C, Newberry S, Maglione M et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 2008; 148: 197-213.
    • (2008) Ann Intern Med , vol.148 , pp. 197-213
    • MacLean, C.1    Newberry, S.2    Maglione, M.3
  • 419
    • 42049099742 scopus 로고    scopus 로고
    • In vivo magnetic resonance detects rapid remodeling changes in the topology of the trabecular bone network after menopause and the protective effect of estradiol
    • Wehrli FW, Ladinsky GA, Jones C et al. In vivo magnetic resonance detects rapid remodeling changes in the topology of the trabecular bone network after menopause and the protective effect of estradiol. J Bone Miner Res 2008; 23: 730-740.
    • (2008) J Bone Miner Res , vol.23 , pp. 730-740
    • Wehrli, F.W.1    Ladinsky, G.A.2    Jones, C.3
  • 420
    • 33744932166 scopus 로고    scopus 로고
    • Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography
    • Borah B, Dufresne TE, Ritman EL et al. Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography. Bone 2006; 39: 345-352.
    • (2006) Bone , vol.39 , pp. 345-352
    • Borah, B.1    Dufresne, T.E.2    Ritman, E.L.3
  • 421
    • 0033755981 scopus 로고    scopus 로고
    • Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
    • Boivin GY, Chavassieux PM, Santora AC et al. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 2000; 27: 687-694.
    • (2000) Bone , vol.27 , pp. 687-694
    • Boivin, G.Y.1    Chavassieux, P.M.2    Santora, A.C.3
  • 422
    • 0033373388 scopus 로고    scopus 로고
    • The design of mineralised hard tissues for their mechanical functions
    • Currey JD. The design of mineralised hard tissues for their mechanical functions. J Exp Biol 1999; 202: 3285-3294.
    • (1999) J Exp Biol , vol.202 , pp. 3285-3294
    • Currey, J.D.1
  • 423
    • 0029886359 scopus 로고    scopus 로고
    • Bisphosphonates: A review of their pharmacokinetic properties
    • Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996; 18: 75-85.
    • (1996) Bone , vol.18 , pp. 75-85
    • Lin, J.H.1
  • 424
    • 68249144735 scopus 로고    scopus 로고
    • Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women
    • Tanko LB, Qin G, Alexandersen P et al. Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women. Osteoporos Int 2004; 10: 10.
    • (2004) Osteoporos Int , vol.10 , pp. 10
    • Tanko, L.B.1    Qin, G.2    Alexandersen, P.3
  • 425
    • 0036787453 scopus 로고    scopus 로고
    • Progression of coronary artery calcification in patients taking alendronate for osteoporosis
    • Hill JA, Goldin JG, Gjertson D et al. Progression of coronary artery calcification in patients taking alendronate for osteoporosis. Acad Radiol 2002; 9: 1148-1152.
    • (2002) Acad Radiol , vol.9 , pp. 1148-1152
    • Hill, J.A.1    Goldin, J.G.2    Gjertson, D.3
  • 426
    • 4544291461 scopus 로고    scopus 로고
    • Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis
    • Nitta K, Akiba T, Suzuki K et al. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 2004; 44: 680-688.
    • (2004) Am J Kidney Dis , vol.44 , pp. 680-688
    • Nitta, K.1    Akiba, T.2    Suzuki, K.3
  • 427
    • 33748171925 scopus 로고    scopus 로고
    • Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone
    • Whitson HE, Lobaugh B, Lyles KW. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone. Bone 2006; 39: 954-958.
    • (2006) Bone , vol.39 , pp. 954-958
    • Whitson, H.E.1    Lobaugh, B.2    Lyles, K.W.3
  • 428
    • 33646837806 scopus 로고    scopus 로고
    • Bisphosphonate-induced hypocalcemia: Report of 3 cases and review of literature
    • Maalouf NM, Heller HJ, Odvina CV et al. Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature. Endocr Pract 2006; 12: 48-53.
    • (2006) Endocr Pract , vol.12 , pp. 48-53
    • Maalouf, N.M.1    Heller, H.J.2    Odvina, C.V.3
  • 429
    • 34147179587 scopus 로고    scopus 로고
    • Subtrochanteric insufficiency fractures in patients on alendronate therapy: A caution
    • Goh SK, Yang KY, Koh JS et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 2007; 89: 349-353.
    • (2007) J Bone Joint Surg Br , vol.89 , pp. 349-353
    • Goh, S.K.1    Yang, K.Y.2    Koh, J.S.3
  • 430
    • 40949099444 scopus 로고    scopus 로고
    • Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate
    • Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008; 358: 1304-1306.
    • (2008) N Engl J Med , vol.358 , pp. 1304-1306
    • Lenart, B.A.1    Lorich, D.G.2    Lane, J.M.3
  • 431
    • 33845890326 scopus 로고    scopus 로고
    • Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial
    • Black DM, Schwartz AV, Ensrud KE et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 2006; 296: 2927-2938.
    • (2006) JAMA , vol.296 , pp. 2927-2938
    • Black, D.M.1    Schwartz, A.V.2    Ensrud, K.E.3
  • 432
    • 0242413030 scopus 로고    scopus 로고
    • Recombinant human parathyroid hormone (1-34) teriparatide improves both cortical and cancellous bone structure
    • Jiang Y, Zhao JJ, Mitlak BH et al. Recombinant human parathyroid hormone (1-34) teriparatide improves both cortical and cancellous bone structure. J Bone Miner Res 2003; 18: 1932-1941.
    • (2003) J Bone Miner Res , vol.18 , pp. 1932-1941
    • Jiang, Y.1    Zhao, J.J.2    Mitlak, B.H.3
  • 433
    • 20844432225 scopus 로고    scopus 로고
    • Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters
    • Arlot M, Meunier PJ, Boivin G et al. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res 2005; 20: 1244-1253.
    • (2005) J Bone Miner Res , vol.20 , pp. 1244-1253
    • Arlot, M.1    Meunier, P.J.2    Boivin, G.3
  • 434
    • 0141684971 scopus 로고    scopus 로고
    • The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
    • Black DM, Greenspan SL, Ensrud KE et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003; 349: 1207-1215.
    • (2003) N Engl J Med , vol.349 , pp. 1207-1215
    • Black, D.M.1    Greenspan, S.L.2    Ensrud, K.E.3
  • 435
    • 0141796739 scopus 로고    scopus 로고
    • The effects of parathyroid hormone, alendronate, or both in men with osteoporosis
    • Finkelstein JS, Hayes A, Hunzelman JL et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. NEngl J Med 2003; 349: 1216-1226.
    • (2003) NEngl J Med , vol.349 , pp. 1216-1226
    • Finkelstein, J.S.1    Hayes, A.2    Hunzelman, J.L.3
  • 436
    • 0027457867 scopus 로고
    • Human parathyroid peptide treatment of vertebral osteoporosis
    • Reeve J, Arlot ME, Bradbeer JN et al. Human parathyroid peptide treatment of vertebral osteoporosis. Osteoporos Int 1993; 3 (Suppl 1): 199-203.
    • (1993) Osteoporos Int , vol.3 , Issue.SUPPL. 1 , pp. 199-203
    • Reeve, J.1    Arlot, M.E.2    Bradbeer, J.N.3
  • 437
    • 0035158179 scopus 로고    scopus 로고
    • Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys
    • Burr DB, Hirano T, Turner CH et al. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 2001; 16: 157-165.
    • (2001) J Bone Miner Res , vol.16 , pp. 157-165
    • Burr, D.B.1    Hirano, T.2    Turner, C.H.3
  • 438
    • 0033581212 scopus 로고    scopus 로고
    • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    • Ettinger B, Black DM, Mitlak BH et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282: 637-645.
    • (1999) JAMA , vol.282 , pp. 637-645
    • Ettinger, B.1    Black, D.M.2    Mitlak, B.H.3
  • 439
    • 33745876266 scopus 로고    scopus 로고
    • Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
    • Barrett-Connor E, Mosca L, Collins P et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl JMed 2006; 355: 125-137.
    • (2006) N Engl JMed , vol.355 , pp. 125-137
    • Barrett-Connor, E.1    Mosca, L.2    Collins, P.3
  • 440
    • 33745249570 scopus 로고    scopus 로고
    • Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial
    • Vogel VG, Costantino JP, Wickerham DL et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006; 295: 2727-2741.
    • (2006) JAMA , vol.295 , pp. 2727-2741
    • Vogel, V.G.1    Costantino, J.P.2    Wickerham, D.L.3
  • 441
    • 48149088817 scopus 로고    scopus 로고
    • The effect of raloxifene treatment in postmenopausal women with CKD
    • Ishani A, Blackwell T, Jamal SA et al. The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol 2008; 19: 1430-1438.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1430-1438
    • Ishani, A.1    Blackwell, T.2    Jamal, S.A.3
  • 442
    • 0344826837 scopus 로고    scopus 로고
    • Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism
    • Lu KC, Yeung LK, Lin SH et al. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 2003; 42: 1221-1227.
    • (2003) Am J Kidney Dis , vol.42 , pp. 1221-1227
    • Lu, K.C.1    Yeung, L.K.2    Lin, S.H.3
  • 443
    • 39749185772 scopus 로고    scopus 로고
    • Bisphosphonate use in chronic kidney disease associated with adynamic bone disease
    • 12-15 October, Copenhagen, Denmark. International Society of Nephrology ISN, Brussels, Belgium
    • Amerling R, Harbord N, Winchester JF et al. Bisphosphonate use in chronic kidney disease associated with adynamic bone disease. Abstract from the ISN Nexus Symposium on the Bone and the Kidney, 12-15 October 2006, Copenhagen, Denmark. International Society of Nephrology (ISN): Brussels, Belgium, 2006, p 33.
    • (2006) Abstract from the ISN Nexus Symposium on the Bone and the Kidney , pp. 33
    • Amerling, R.1    Harbord, N.2    Winchester, J.F.3
  • 444
    • 0038188551 scopus 로고    scopus 로고
    • Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis
    • Hernandez E, Valera R, Alonzo E et al. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 2003; 63: 2269-2274.
    • (2003) Kidney Int , vol.63 , pp. 2269-2274
    • Hernandez, E.1    Valera, R.2    Alonzo, E.3
  • 445
    • 0031950095 scopus 로고    scopus 로고
    • Growth in renal failure: A longitudinal study of emotional and behavioural changes during trials of growth hormone treatment
    • Postlethwaite RJ, Eminson DM, Reynolds JM et al. Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment. Arch Dis Child 1998; 78: 222-229.
    • (1998) Arch Dis Child , vol.78 , pp. 222-229
    • Postlethwaite, R.J.1    Eminson, D.M.2    Reynolds, J.M.3
  • 446
    • 38349071130 scopus 로고    scopus 로고
    • Abnormal bone and mineral metabolism in kidney transplant patients - a review
    • Sprague SM, Belozeroff V, Danese MD et al. Abnormal bone and mineral metabolism in kidney transplant patients - a review. Am J Nephrol 2008; 28: 246-53.
    • (2008) Am J Nephrol , vol.28 , pp. 246-253
    • Sprague, S.M.1    Belozeroff, V.2    Danese, M.D.3
  • 447
    • 0025788833 scopus 로고
    • Rapid loss of vertebral mineral density after renal transplantation
    • Julian BA, Laskow DA, Dubovsky J et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544-550.
    • (1991) N Engl J Med , vol.325 , pp. 544-550
    • Julian, B.A.1    Laskow, D.A.2    Dubovsky, J.3
  • 449
    • 0034085591 scopus 로고    scopus 로고
    • High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation
    • Monier-Faugere MC, Mawad H, Qi Q et al. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. JAm Soc Nephrol 2000; 11: 1093-1099.
    • (2000) JAm Soc Nephrol , vol.11 , pp. 1093-1099
    • Monier-Faugere, M.C.1    Mawad, H.2    Qi, Q.3
  • 450
    • 17744367834 scopus 로고    scopus 로고
    • Clinical impact of preexisting vascular calcifications on mortality after renal transplantation
    • Hernandez D, Rufino M, Bartolomei S et al. Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int 2005; 67: 2015-2020.
    • (2005) Kidney Int , vol.67 , pp. 2015-2020
    • Hernandez, D.1    Rufino, M.2    Bartolomei, S.3
  • 451
    • 4544273367 scopus 로고    scopus 로고
    • Natural history of vascular calcification in dialysis and transplant patients
    • Moe SM, O'Neill KD, Reslerova M et al. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 2004; 19: 2387-2393.
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 2387-2393
    • Moe, S.M.1    O'Neill, K.D.2    Reslerova, M.3
  • 452
    • 34547543727 scopus 로고    scopus 로고
    • Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure
    • Egbuna OI, Taylor JG, Bushinsky DA et al. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant 2007; 21: 558-566.
    • (2007) Clin Transplant , vol.21 , pp. 558-566
    • Egbuna, O.I.1    Taylor, J.G.2    Bushinsky, D.A.3
  • 454
    • 33646781250 scopus 로고    scopus 로고
    • Post-renal transplantation hypophosphatemia: A review and novel insights
    • Ghanekar H, Welch BJ, Moe OW et al. Post-renal transplantation hypophosphatemia: a review and novel insights. Curr Opin Nephrol Hypertens 2006; 15: 97-104.
    • (2006) Curr Opin Nephrol Hypertens , vol.15 , pp. 97-104
    • Ghanekar, H.1    Welch, B.J.2    Moe, O.W.3
  • 455
    • 36248954561 scopus 로고    scopus 로고
    • Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft
    • Yakupoglu HY, Corsenca A, Wahl P et al. Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft. Transplantation 2007; 84: 1151-1157.
    • (2007) Transplantation , vol.84 , pp. 1151-1157
    • Yakupoglu, H.Y.1    Corsenca, A.2    Wahl, P.3
  • 456
    • 33846970888 scopus 로고    scopus 로고
    • Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients
    • Schaeffner ES, Fodinger M, Kramar R et al. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int 2007; 20: 247-255.
    • (2007) Transpl Int , vol.20 , pp. 247-255
    • Schaeffner, E.S.1    Fodinger, M.2    Kramar, R.3
  • 457
    • 6844254546 scopus 로고    scopus 로고
    • Parathyroid function in long-term renal transplant patients: Importance of pre-transplant PTH concentrations
    • Torres A, Rodriguez AP, Concepcion MT et al. Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. Nephrol Dial Transplant 1998; 13 (Suppl 3): 94-97.
    • (1998) Nephrol Dial Transplant , vol.13 , Issue.SUPPL. 3 , pp. 94-97
    • Torres, A.1    Rodriguez, A.P.2    Concepcion, M.T.3
  • 458
    • 0030721711 scopus 로고    scopus 로고
    • Parathyroidectomy after renal transplantation: A retrospective analysis of long-term outcome
    • Schmid T, Muller P, Spelsberg F. Parathyroidectomy after renal transplantation: a retrospective analysis of long-term outcome. Nephrol Dial Transplant 1997; 12: 2393-2396.
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 2393-2396
    • Schmid, T.1    Muller, P.2    Spelsberg, F.3
  • 459
    • 0038001511 scopus 로고    scopus 로고
    • Hyperparathyroidism and long-term bone loss after renal transplantation
    • Heaf J, Tvedegaard E, Kanstrup IL et al. Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant 2003; 17: 268-274.
    • (2003) Clin Transplant , vol.17 , pp. 268-274
    • Heaf, J.1    Tvedegaard, E.2    Kanstrup, I.L.3
  • 460
    • 0030906423 scopus 로고    scopus 로고
    • No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients
    • Dumoulin G, Hory B, Nguyen NU et al. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients. Am J Kidney Dis 1997; 29: 746-753.
    • (1997) Am J Kidney Dis , vol.29 , pp. 746-753
    • Dumoulin, G.1    Hory, B.2    Nguyen, N.U.3
  • 461
    • 34447514029 scopus 로고    scopus 로고
    • Vitamin D deficiency
    • Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
    • (2007) N Engl J Med , vol.357 , pp. 266-281
    • Holick, M.F.1
  • 463
    • 42949157278 scopus 로고    scopus 로고
    • Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs)
    • Reichrath J, Nurnberg B. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol 2008; 624: 203-214.
    • (2008) Adv Exp Med Biol , vol.624 , pp. 203-214
    • Reichrath, J.1    Nurnberg, B.2
  • 464
    • 56049089905 scopus 로고    scopus 로고
    • Can DXA predict fractures in renal transplant patients?
    • Akaberi S, Simonsen O, Lindergard B et al. Can DXA predict fractures in renal transplant patients? Am J Transplant 2008; 8: 2647-2651.
    • (2008) Am J Transplant , vol.8 , pp. 2647-2651
    • Akaberi, S.1    Simonsen, O.2    Lindergard, B.3
  • 465
    • 0033504941 scopus 로고    scopus 로고
    • The role of vitamin D in corticosteroid-induced osteoporosis: A meta-analytic approach
    • Amin S, LaValley MP, Simms RW et al. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. Arthritis Rheum 1999; 42: 1740-1751.
    • (1999) Arthritis Rheum , vol.42 , pp. 1740-1751
    • Amin, S.1    LaValley, M.P.2    Simms, R.W.3
  • 466
    • 0036014943 scopus 로고    scopus 로고
    • Treatment with vitamin D and calcium reduces bone loss after renal transplantation: A randomized study
    • De Sevaux RG, Hoitsma AJ, Corstens FH et al. Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 2002; 13: 1608-1614.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 1608-1614
    • De Sevaux, R.G.1    Hoitsma, A.J.2    Corstens, F.H.3
  • 467
    • 1642520760 scopus 로고    scopus 로고
    • Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation
    • Torres A, Garcia S, Gomez A et al. Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 2004; 65: 705-712.
    • (2004) Kidney Int , vol.65 , pp. 705-712
    • Torres, A.1    Garcia, S.2    Gomez, A.3
  • 468
    • 7044254622 scopus 로고    scopus 로고
    • Calcium and calcitriol prophylaxis attenuates posttransplant bone loss
    • Josephson MA, Schumm LP, Chiu MY et al. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation 2004; 78: 1233-1236.
    • (2004) Transplantation , vol.78 , pp. 1233-1236
    • Josephson, M.A.1    Schumm, L.P.2    Chiu, M.Y.3
  • 469
    • 10744232811 scopus 로고    scopus 로고
    • Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate
    • Coco M, Glicklich D, Faugere MC et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 2003; 14: 2669-2676.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 2669-2676
    • Coco, M.1    Glicklich, D.2    Faugere, M.C.3
  • 470
    • 0033979597 scopus 로고    scopus 로고
    • Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation
    • Cueto-Manzano AM, Konel S, Freemont AJ et al. Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am J Kidney Dis 2000; 35: 227-236.
    • (2000) Am J Kidney Dis , vol.35 , pp. 227-236
    • Cueto-Manzano, A.M.1    Konel, S.2    Freemont, A.J.3
  • 471
    • 0345446519 scopus 로고    scopus 로고
    • Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate
    • Jeffery JR, Leslie WD, Karpinski ME et al. Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. Transplantation 2003; 76: 1498-1502.
    • (2003) Transplantation , vol.76 , pp. 1498-1502
    • Jeffery, J.R.1    Leslie, W.D.2    Karpinski, M.E.3
  • 472
    • 49249138330 scopus 로고    scopus 로고
    • Bisphosphonates and bone fractures in long-term kidney transplant recipients
    • Conley E, Muth B, Samaniego M et al. Bisphosphonates and bone fractures in long-term kidney transplant recipients. Transplantation 2008; 86: 231-237.
    • (2008) Transplantation , vol.86 , pp. 231-237
    • Conley, E.1    Muth, B.2    Samaniego, M.3
  • 473
    • 4043158429 scopus 로고    scopus 로고
    • Treatment of osteopenia and osteoporosis in renal transplant children and adolescents
    • El-Husseini AA, El-Agroudy AE, El-Sayed MF et al. Treatment of osteopenia and osteoporosis in renal transplant children and adolescents. Pediatr Transplant 2004; 8: 357-361.
    • (2004) Pediatr Transplant , vol.8 , pp. 357-361
    • El-Husseini, A.A.1    El-Agroudy, A.E.2    El-Sayed, M.F.3
  • 474
    • 10044255504 scopus 로고    scopus 로고
    • A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents
    • El-Husseini AA, El-Agroudy AE, El-Sayed M et al. A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents. Am J Transplant 2004; 4: 2052-2057.
    • (2004) Am J Transplant , vol.4 , pp. 2052-2057
    • El-Husseini, A.A.1    El-Agroudy, A.E.2    El-Sayed, M.3
  • 476
    • 33845370793 scopus 로고    scopus 로고
    • Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment
    • Miller PD, Schwartz EN, Chen P et al. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 2007; 18: 59-68.
    • (2007) Osteoporos Int , vol.18 , pp. 59-68
    • Miller, P.D.1    Schwartz, E.N.2    Chen, P.3
  • 477
    • 12344258729 scopus 로고    scopus 로고
    • A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids
    • Wissing KM, Broeders N, Moreno-Reyes R et al. A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 2005; 79: 108-115.
    • (2005) Transplantation , vol.79 , pp. 108-115
    • Wissing, K.M.1    Broeders, N.2    Moreno-Reyes, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.